Law Updates

Subject

Summary: The Food Safety and Standards Authority of India (FSSAI) issued the FSSAI LC-HRMS specifications 2026. The specifications cover Liquid Chromatography-High Resolution Mass Spectrometry systems that are used for advanced food, feed, and water testing. The notice provides details on the LC-QToF and LC-Q-Orbitrap systems. It covers the instrument, chromatography system, software, databases, workstations, gas supply, power backup, accessories, testing evidence, training, warranty, and after-sales support. The most important point is its legal nature. FSSAI has clearly stated that these specifications are purely indicative. They are not standard tender specifications or mandatory procurement conditions. Procuring agencies may change any parameter after assessing their operational needs. This update pertains to procurement of laboratories, equipment manufacturers, authorized suppliers, technical evaluation committee, and bid teams. This update is not meant for every food business or every food testing laboratory to buy an LC-HRMS system. The FSSAI notice clearly states that the specification mentioned is only indicative. Background of the LC-HRMS Procurement Framework The FSSAI is a scientific authority established under the Food Safety and Standards Act, 2006. Its functions are related to food safety standards, testing systems, laboratory capacity, and scientific assessment. Liquid Chromatography-High Resolution Mass Spectrometry is used to separate, detect, and identify chemicals in complex samples. It can detect very small quantities of contaminants and generate accurate information about their molecular mass. An LC-HRMS laboratory may use the technology for: Pesticide residue analysis. Antibiotic and veterinary drug testing. Pharmaceuticals and personal care product screening. Water contaminant analysis. Food and feed contaminant testing. Metabolomics and lipidomics. Honey adulteration and floral-origin assessment. Targeted measurement of known compounds. Untargeted screening of unknown compounds. The instrument cannot operate effectively as a standalone machine. It needs chromatography, software, spectral libraries, data-processing systems, gases, uninterrupted power supply, qualified staff, and ongoing maintenance. FSSAI's annexure addresses these related requirements as a single package. Earlier regulatory position The notice does not identify an earlier LC-HRMS specification that has been amended, withdrawn, or replaced. It also does not provide an old-versus-new comparison. The correct interpretation is that FSSAI has finalised a suggestive technical reference. The source does not support a claim that an earlier statutory requirement has changed. Why Has FSSAI Issued These Specifications? The express purpose is to provide finalised suggestive specifications for LC-HRMS equipment. FSSAI does not give a detailed policy explanation beyond this point. In the case of procurement-related problems, this is very useful because it requires evaluating laboratory devices across many criteria. It means that comparing their mass resolution or sensitivity alone will not be enough. The specifications place attention on: The analytical work that the system must perform. Measurable instrument performance. Software and database capabilities. Laboratory infrastructure and utilities. Performance evidence from the vendor. Staff training and method-development support. Warranty and maintenance coverage. Post-warranty service and spare-part availability. This procurement context is a reasonable business interpretation. It should not be presented as a separate legal objective unless FSSAI states it in another official document. What Has Been Introduced? FSSAI has introduced an end-to-end reference containing 26 grouped requirement areas. New requirement area Who it concerns Main requirement Business meaning Analytical applications Laboratories and vendors Support targeted, untargeted and authentication workflows The complete solution must meet the laboratory’s intended work UHPLC system Equipment suppliers Meet proposed flow, pressure, accuracy and autosampler conditions Chromatography performance becomes part of bid evaluation Mass spectrometer Manufacturers and technical committees Meet proposed flow, pressure, accuracy and autosampler conditions Vendors need measurable proof of instrument performance Software and databases Vendors and laboratory analysts Supply licensed software, libraries and processing workflows Software scope cannot be treated as an optional extra Laboratory utilities Suppliers and facility teams Supply vacuum, gas and power backup systems Site infrastructure becomes part of procurement planning Performance evidence Bid teams Submit application notes, curves, data sheets and user evidence Claims must be supported by records Training and validation Vendors and laboratory personnel Provide basic and advanced training Knowledge transfer becomes a supply obligation Warranty and service Vendors and procurement teams Provide multi-year support and maintenance Lifecycle cost and service capacity affect evaluation Accessories and consumables Suppliers Supply listed supporting items and initial consumables The package is expected to be ready for installation and use Requirement-Wise Analysis of the LC-HRMS Specifications Application requirements The proposed system must be a high-resolution accurate-mass LC-QToF or LC-Q-Orbitrap system. All software and accessories needed for its successful operation should form part of the solution. The system is expected to support four broad workflows. Contaminant screening and measurement The equipment should perform simultaneous untargeted screening and quantification of chemical contaminants in food, feed and water. The notice specifically refers to: Antibiotics. Veterinary drugs. Pharmaceuticals and Personal Care Products. Water contaminants. Pesticide residues. Other small molecules. The solution should collect full-scan and tandem mass spectrometry data. It must also include databases for accurate-mass and MS/MS spectral matching. Targeted analysis The platform should support targeted measurement via high-resolution Multiple Reaction Monitoring or an equivalent data acquisition mode. Targeted analysis looks for selected compounds. It differs from untargeted screening, which searches more broadly for known and unknown chemicals. Metabolomics and lipidomics Metabolomics studies small molecules produced during biological processes. Lipidomics focuses on fats and related molecules. The software should support: Peak alignment and peak picking. Grouping of adducts. Metabolite annotation. Lipid annotation. Expandable databases. Pathway mapping. Multivariate statistics. Biomarker selection. Honey Authentication The proposed system is expected to authenticate honey, oligosaccharides, adulteration, and floral characteristics. Vendors must submit data connected with honey authentication as part of the technical evidence. UHPLC System Requirements Ultra-High Performance Liquid Chromatography separates chemicals before they enter the mass spectrometer. The UHPLC and mass spectrometer should work together through the supplied operating software. Parameter Indicative requirement Practical significance Pump Binary high-pressure pump with built-in degasser Supports controlled solvent delivery Operating flow 0.1 to 2.000 mL/min or better Covers the proposed analytical flow range Operating pressure 15,000 psi or better at 1 mL/min or better Supports high-pressure separation Flow accuracy ±1% Helps maintain repeatable retention conditions Degasser Four-channel vacuum degasser Removes dissolved gases from solvents Flow precision ≤0.07% Relative Standard Deviation or better Supports repeatable chromatography Autosampler Refrigerated Helps protect prepared samples Sample capacity At least 96 vials of 1.5-2 mL and support for 96/384-well plates Supports batch testing Injection range 0.1-100 µL Allows different sample volumes Injection accuracy ±1.0% Supports repeatable injection Carryover Below 0.004% for caffeine/chlorhexidine or better Reduces contamination between samples Column oven At least two columns with software-controlled switching Supports multiple analytical methods Oven range Ambient temperature to 85°C or better Allows temperature-controlled separation C18 columns Five columns, 2.1 × 100 mm, sub-2 µm or equivalent Supports specified residue and research workflows Mass Spectrometer Requirements Ion sources The system should include dedicated Electrospray Ionisation and Atmospheric Pressure Chemical Ionisation sources. The sources should: Cover the proposed application areas. Be easy for the operator to interchange. Allow automatic probe detection by the instrument and software. Permit source cleaning without disturbing the vacuum. Handle flow rates from 1-1,000 µL/min or better without splitting. Provide a desolvation temperature of at least 400 °C. Mass analyser and performance parameters Parameter Indicative requirement Practical significance Mass analyser QToF or Q-Orbitrap Allows high-resolution accurate-mass analysis Quadrupole mass range At least 50-2,200 atomic mass units or better Covers the stated mass range Resolution 70,000 or higher, or 60,000 or higher with ion mobility Supports separation of closely related ions QToF acquisition speed At least 40 MS/MS spectra per second or better Supports fast data collection Orbitrap scan speed At least 22 Hz or better Sets the proposed Orbitrap speed Mass accuracy Stated as “minimum 1 PPM” in MS and MS/MS modes Supports accurate mass assignment Dynamic range Five orders or better Supports signals across different concentration levels Screening sensitivity Sub-ppb or femtomole levels, with SDL below 5 ppb or better Supports trace contaminant screening Application-note method LOQ Below 5 ppb for pesticide or antibiotic residues Requires application-level evidence Parts per billion measures very small concentrations. A Limit of Quantification is the lowest level that a method can measure with acceptable performance. A Screening Detection Limit indicates whether screening can reliably detect an analyte at a specified level. Mass-accuracy evidence A brochure statement is not enough. The vendor must provide documents showing mass accuracy over 24 hours or more of consecutive on-column injections. The purpose is to demonstrate stability over longer metabolomics cohort analyses. The final tender should define the test conditions so that all vendors are assessed on the same basis. Sensitivity evidence Vendors must state the sensitivity achieved in Data Independent Acquisition and MS/MS modes. They must also provide and demonstrate: Application notes showing pesticide or antibiotic residue analysis below a 5 ppb method LOQ. Calibration curves for relevant contaminants. Data from DIA and high-resolution MRM modes. The source does not name the analytes, matrices, number of injections, or statistical acceptance rules for this demonstration. The procuring agency should define these points in its final tender. Data-Acquisition Requirements The system should support several data-acquisition modes. Variable-window acquisition in the first quadrupole for Data Independent Acquisition. Full-scan mass spectra. Selected Ion Monitoring for target compounds. MRM, PRM, SRM or similar reaction-monitoring datasets. Timed SIM for scheduled target-compound acquisition. Timed MS/MS for scheduled fragment-spectrum acquisition. Dynamic exclusion of selected ions while collecting MS/MS spectra for less-abundant precursor ions. These modes allow the same platform to support broad screening, confirmatory identification, and targeted measurement. Software, Databases and Workstation Requirements Licensing and instrument control The notice calls for original and licensed universal perpetual software. Free upgrades should be provided for up to five years. All hardware and software needed for instrument control, data acquisition and processing should be included. The operating software should control the complete UHPLC-HRMS system. It should also provide: System-suitability calculations. User-designed report formats. Background subtraction. Elemental-composition analysis. Component differential analysis. Targeted and untargeted screening. Compound and library searches. Fragment prediction. Quantitative and qualitative analysis. Acquisition and processing computers System Proposed configuration Acquisition computer One high-performance computer with factory-recommended processor and operating system Acquisition memory At least 32 GB RAM Acquisition storage At least 2 TB Acquisition display 24-inch high-resolution monitor Processing computer One computer with Intel i7 processor and Windows 10 Professional Processing memory 64 GB RAM Processing storage 10 TB Processing display 28-inch high-resolution monitor Additional hardware Wireless keyboards, mice and laser printer with printing, copying and scanning Office software Microsoft Office Professional Application software and spectral databases The proposed software should include current high-resolution mass spectral libraries and fragment information for pesticides, antibiotics, and small molecules. Required functions include: Automatic searching of free and commercial libraries. Automatic searching of user-created libraries. User-editable target databases. Empirical-formula generation from mass spectra. Fragment prediction for metabolite identification. Targeted and untargeted metabolomics. Lipidomics analysis. Pathway-based target-list generation. Selection of MS or MS/MS ions for quantification. Qualitative, quantitative and characterisation workflows. The solution should contain ready-to-use acquisition and processing methods for at least 300 contaminants. It should include predefined columns, quality-control samples and settings so the methods can work after installation. Advanced analysis and reporting The software should support: Grouping isotopes, charge states, adducts and fragments into one feature. Rapid recognition of known compounds. Annotation-quality scoring. Principal Component Analysis. Analysis of Variance. T-tests. Hierarchical Cluster Analysis. Structure searches using elemental composition. In silico fragmentation. Client-server processing. Remote access to data. Export to third-party statistical and pathway tools. Combination of data from different mass analysers. False-discovery discrimination. Grouping of environmental pollutants. Biological interpretation of identified metabolites. Vacuum, Gas and Power Requirements The package includes the utilities needed to operate the instrument. Vacuum system The proposed vacuum system should be oil-less, efficient and low-noise. It should include an automatic vacuum lock and safety features that protect the instrument. All accessories required for proper vacuum operation must be included in the supply. Nitrogen and other gases A nitrogen generator should be included with: Minimum nitrogen purity of 99.9%. Adequate flow for the proposed HRMS instrument. Compressor, gas regulators and filters. Required connectors and tubing. If another gas is needed, such as collision gas, the supplier should disclose it. At least two cylinders, regulators and connectors should then be supplied. The gas arrangement should use as little laboratory space as possible. It should also maintain laboratory safety and access to work. The vendor must provide an affirmation for this condition. Gas-cylinder documents The following documents must be supplied with the cylinders: Manufacturer certificate. Hydrostatic test certificate. Chief Controller of Explosives, Nagpur gas-filling approval certificate. Purity certificate. Uninterrupted power supply The package should contain an online 20 kVA or better Uninterrupted Power Supply. It must provide at least two hours of backup for: The LC-HRMS system. The vacuum pump. The nitrogen generator. The battery should be placed in a suitable rack. Required power connections and accessories must also be supplied. Warranty, Service and Post-Warranty Requirements Five-year system warranty The system and supporting accessories should carry a minimum five-year warranty. The period starts after completion of Installation Qualification, Operational Qualification and Performance Qualification. These three qualification stages confirm that the equipment has been installed correctly, operates properly, and performs the required applications. The warranty should cover: LC-HRMS hardware. Nitrogen generator and compressor. Vacuum system. UPS and batteries. Computers and printer. Gas cylinders and accessories. Software. Wear-and-tear consumables, except columns and sample-preparation items. Training and application support. Applicable software upgrades. Ten-year component warranty The heated ESI/APCI ion source and detector should have a ten-year warranty. The final tender should clearly define which source and detector components are covered. This can prevent later disputes about excluded components. Breakdown response and preventive maintenance A vendor should attend to service calls within 48 hours during the five-year warranty period. Other parts of the annexure use a 24-48-hour service period. The specifications also require: Immediate servicing after a breakdown. Maximum stated downtime of 24-48 hours. Warranty extension if a breakdown is not attended within the stated period. At least two preventive-maintenance visits each year. Preventive-maintenance kits when required. The final contract should define when the response period begins, what constitutes attendance, and how a warranty extension will be calculated. After-sales and post-warranty support The supplier should have an application laboratory in India or abroad. It should also have trained service engineers in nearby metropolitan areas. Post-warranty requirements include: Unlimited breakdown visits by service or application engineers. Free troubleshooting training when required. Application and method-development support. Supply of spares, accessories, consumables and service for at least ten years. Separate AMC and CMC quotations for three years after warranty. Separate terms and price breakup for AMC and CMC. Use of the three-year AMC price while finalising the lowest evaluated bidder. FSSAI does not state any AMC or CMC amount. Each supplier must quote the applicable price under the final tender. Demonstration, Training and Validation Requirements The supplier is responsible for training laboratory personnel at the supplier's site or installation site. The package should provide: Basic training for at least ten working days after installation. Method development support during the warranty and AMC periods. One general entry-level workshop at the user site. One advanced workshop at the user site. Training on experiments and data analysis. Instrument and application troubleshooting. Support for developing and validating at least one priority parameter selected by the laboratory. On-site performance validation against laboratory or regulatory protocols. The final tender should specify the number of trainees, course content, training records and expected competency level. Accessories and Initial Consumables Item Indicative quantity or requirement HPLC and MS preventive-maintenance kits Enough for the warranty period Single-channel micropipettes, 50-1,000 µL 4 Single-channel micropipettes, 10-100 µL 4 Single-channel micropipettes, 1,000-5,000 µL 2 Capillary tubes, cones, desolvation lines or similar accessories 10 Calibration and tuning standards All standards needed for MS and HPLC calibration Clear vials, 1.5/2.0 mL 1,000 Amber vials, 1.5/2.0 mL 2,000 13 mm syringe PTFE filters 1,000; pore size appears as “022µ” in the source Standard maintenance toolkit Required Solvent filtration unit with pump Required Mobile-phase bottles, 500 mL 12 Mobile-phase bottles, 1,000 mL 12, followed by another reference to 12 one-litre bottles Low-volume 500 µL recovery vials 1,000 QuEChERS pesticide-extraction kits 1,000 Heavy-duty multi-tube vortex mixer 1 Rack for 50 × 1.5/2 mL tubes 2 or more Rack for 50 × 15 mL tubes 2 or more Rack for 15 × 50 mL tubes 6 or more Horizontal QuEChERS rack for 9 × 50 mL tubes 2 or more The proposed vortex mixer should have: A speed range of 500-2,500 rpm or better. A timer from one minute to 99 hours and 59 minutes or better. An orbit of 3.0 mm or better. A 100-240 V and 50-60 Hz electrical range. An operating range from +5°C to +50°C or better. Support for horizontal and vertical mixing. Scope and Applicability The notice applies as a technical reference for the procurement of LC-HRMS equipment. Its practical effect differs across stakeholders. Stakeholder Covered? Relevant condition Main responsibility Procuring agencies Directly relevant Specifications are indicative Assess operational needs and prepare the final tender Food testing laboratories Directly relevant when procuring equipment System must suit the laboratory’s work Define applications, methods and site requirements Equipment manufacturers Commercially relevant Performance claims need evidence Supply verified technical information Authorised suppliers and distributors Commercially relevant Complete package and service support may be required Coordinate hardware, software, warranty and local support Technical evaluation committees Directly relevant when formed Agencies may form their own committee Review technology and finalise fair tender conditions Food manufacturers and exporters Indirectly affected No purchase duty is created May use laboratories operating this technology General food business operators Not directly covered No licensing or registration change No new action is created by this notice alone Exclusions and limitations The notice does not favour or restrict any manufacturer, technology, supplier or country of origin. It also does not create: A mandatory LC-HRMS purchase requirement. A food business registration process. A laboratory approval procedure. A certification program for the equipment. A mandatory testing schedule. A new food product specification. A compliance date. A transition period. A non-compliance penalty. FSSAI also states that it will not be liable for procurement or contractual issues arising from purchases made by other agencies. Indicative Procurement Requirements The responsibilities in the annexure apply only when a procuring agency adopts them in a tender. Procuring agencies Procuring bodies should independently assess their operational needs. They may modify any specification before issuing the tender. They may also: Form a Technical Evaluation Committee. Consult subject-matter experts. Accept equivalent or better performance. Modify accessory quantities. Change software and workstation requirements. Define site-specific service conditions. Set their own technical evaluation method. Vendors and suppliers Where the final tender adopts the FSSAI benchmark, vendors may need to: Offer a complete LC-HRMS solution. Submit a clause-wise compliance sheet. Support every claim with technical records. Demonstrate residue-testing performance. Provide training and on-site validation. Supply the listed utilities and accessories. Meet warranty and service commitments. Quote post-warranty AMC and CMC prices separately. These are indicative tender responsibilities. They are not general statutory duties imposed on every equipment vendor. Effective Date and Compliance Timeline It does not state a separate effective date, procurement deadline or transition period. The annexure contains several contract-related periods, but these are not statutory compliance deadlines: Software upgrades for up to five years. Minimum five-year system warranty. Ten-year warranty for the heated ion source and detector. Service attendance within 48 hours, with other references to 24-48 hours. At least two preventive-maintenance visits each year. Availability of spares and service for at least ten years. Three years of AMC and CMC quotations after warranty. Basic training for at least ten working days. These periods begin or become binding only when incorporated into an actual tender and contract. How the Notice Differs From the Earlier Position? The attached notice is not described as an amendment or corrigendum. It does not identify an earlier LC-HRMS technical specification or show any parameter that has been substituted. The verified change is the availability of a finalised FSSAI reference for LC-HRMS procurement. No verified old-versus-new technical comparison can be prepared from this notice alone. A procuring agency should therefore treat the document as a new reference point. It should not assume that the notice automatically changes an existing tender or contract. Technical Documentation Required From Vendors Document or record Status in annexure Purpose Responsible party Stage Mass-accuracy records for 24 hours or more Required Show long-run stability Vendor Technical evaluation Application notes below 5 ppb method LOQ Required and demonstrated Support pesticide and antibiotic performance Vendor Evaluation or demonstration Calibration curves Required Support DIA and high-resolution MRM claims Vendor Technical evaluation Service-response affirmation on stamp paper Required Confirm service attendance Vendor Bid submission User reference letter Minimum one Confirm performance and service experience Vendor Bid submission Gas-layout affirmation Required Confirm suitable gas arrangement Vendor Bid submission Cylinder manufacturer certificate Required Verify cylinder source Supplier Delivery Hydrostatic test certificate Required Verify cylinder testing Supplier Delivery CCOE gas-filling approval certificate Required Support gas-filling approval Supplier Delivery Purity certificate Required Verify gas purity Supplier Delivery Proof-of-performance records Required with compliance sheet Support technical claims Vendor Bid submission Original and authenticated data sheets Required Verify offered specifications Vendor Bid submission Honey-authentication data Required Support the proposed application Vendor Technical evaluation Indian user list Required Show installations in India Vendor Bid submission Performance testimonials Minimum two from reputed users Support instrument performance Vendor Bid submission AMC and CMC price breakup Required separately Assess post-warranty cost Vendor Commercial submission One user reference letter and two performance references are needed from the source. It does not make clear if the same user can support both requirements. This needs to be made clear in the final tender. Testing and Performance Validation Performance verification testing must focus on actual performance, not only on brochure specifications. It requires validation of: Mass accuracy in successive injections for 24 hours or more. Pesticide or antibiotic residue analysis below a 5 ppb method LOQ. Sensitivity in DIA and MS/MS modes. Calibration curves in DIA and high-resolution MRM modes. Honey-authentication capability. Ready-to-use workflows for at least 300 contaminants. Onsite validation against laboratory or regulatory protocols. Proof-of-performance documents supporting the compliance sheet. The notice does not provide a complete testing protocol. Procuring agencies should define the sample matrix, analytes, concentration levels, number of replicates and acceptance rules. Impact on Businesses and Stakeholders Procuring laboratories Laboratories receive a detailed starting point for tender preparation. The benchmark may reduce the chance of overlooking software, gas systems, accessories or long-term service. The laboratory must still decide: Which contaminants it plans to test. Required reporting limits and sample throughput. Whether metabolomics and lipidomics are needed. Which software modules are essential. Whether the proposed accessories match existing facilities. How competing technologies will be compared. Equipment manufacturers Manufacturers may need to show both technical performance and application readiness. A system that meets headline hardware values may still fall short on software, databases, training or service. Long warranty periods may also require approval from the original equipment manufacturer rather than only a local distributor. Authorised suppliers and distributors Suppliers may need to coordinate many parts of the package. These include hardware, software licences, gas systems, UPS equipment, accessories, training and post-warranty support. The bid file must clearly identify which organisation is responsible for each commitment. Technical evaluation committees A technical committee must protect both performance and fair competition. The FSSAI notice allows equivalent or better specifications and rejects preference for a particular manufacturer or country. Evaluation criteria should thus be based on measurable outcomes rather than on the product's branding. Food Manufacturers and Exporters The notice places no direct obligation on food manufacturers to provide equipment or testing services. It is an indirect obligation. Improved LC-HRMS capacity may support access to advanced residue analysis, contaminant screening, product investigation and authenticity testing. Any actual testing duty must arise from a separate law, standard, buyer requirement or contract. MSME suppliers Smaller suppliers may face difficulty meeting long warranty periods, India-based service expectations, application support and large accessory requirements. The burden may be reduced through clear rules on consortium, authorisation, and subcontracting in the final tender. The FSSAI notice does not prescribe such arrangements. Cost and Operational Implications The notice fails to provide any figure for the equipment cost, procurement cost, or budget approval. Cost factors include: LC-QToF or LC-Q-Orbitrap unit. UHPLC system and columns. Nitrogen generator and gas accessories. Online 20 kVA UPS and batteries. Acquisition and processing computers. Licensed software and spectral libraries. Initial standards, reagents and consumables. Installation and qualification. Training and method development. Laboratory modifications. Ongoing costs may be affected by: Annual and comprehensive maintenance. Software subscriptions not covered by the perpetual licence. Database renewals. Replacement parts and consumables. Gas and electricity use. Data storage and backups. Preventive maintenance. Staff training. Method validation. A low equipment price may not represent the lowest lifecycle cost. The final tender should state how AMC, CMC, software, and utility costs will be evaluated. Business Benefits of the FSSAI Benchmark A properly adapted procurement benchmark can offer several practical benefits. Complete package planning: It covers the instrument, software, utilities, and accessories. Improved performance evaluation: Accuracy, speed, and sensitivity can be evaluated through their stated numbers. Improved control of evidence: Claims need to be supported by application data and technical documentation. Application preparedness: Since the emphasis is on workflow, there is a lower likelihood of purchasing equipment without a method in place. Staff training and troubleshooting: These are included in the suggested package. Longer service visibility: Warranty, preventive maintenance, and post-warranty support are considered early. Technology neutrality: Procuring agencies may accept equivalent solutions that meet their actual needs. Improved procurement planning: Lifecycle requirements can be reviewed before contract award. The benefit depends on careful adaptation. Using every clause without review may create unnecessary expense or limit competition. Technical and Operational Challenges Comparing different instrument technologies QToF and Q-Orbitrap systems may use different designs and performance-reporting methods. Resolution and scan speed cannot be directly compared using a single number. The tender should state the measurement conditions, the reference mass, and the required performance for the intended acquisition mode. Proving sensitivity The document uses sub-ppb, femtomole, screening detection limit and method LOQ concepts. These measures are not identical. Without a common demonstration plan, suppliers may submit results from different samples, compounds or test conditions. Software scope and licensing A perpetual software licence may not include every database, cloud service or future module. The tender should identify: Included licences. Number of users. Database subscriptions. Remote-access rights. Upgrade costs. Data-export rights. Cybersecurity and backup requirements. Service coverage The source uses both 48 hours and 24-48 hours. It also refers to trained engineers in nearby metropolitan areas without defining "nearby." Remote and difficult locations may need a separate service plan. Long-term commitments A five-year warranty, a ten-year component warranty, and a ten-year spare-parts support promise can pose commercial risk. The procuring agency should verify that the bidder has written support from the original manufacturer. Procurement and Bid Risks The notice does not create statutory penalties. The main risks are technical, operational and contractual. An unsuitable specification may lead to the purchase of an instrument that cannot perform the required applications. Ambiguous performance tests may lead to disagreements during technical evaluation. A lack of documentation may pose a problem if the final tender includes documentation requirements. Ambiguous licensing provisions may lead to future software costs. Insufficient gas or power supply might delay the installation process. Insufficient local service availability might increase downtime. Ambiguous warranty exclusions may lead to disputes over repairs. The brand-specific provisions may limit competition despite the notice's technology-neutral wording. Incorrect treatment of indicative provisions as statutory duties may lead to unnecessary spending. Whether a bid deviation causes rejection will depend on the final tender. The FSSAI notice itself does not create a bid-rejection rule. LC-HRMS Tender Readiness Checklist The following checklist converts source-based requirements into a tender review tool. The intended food, feed or water testing applications have been identified. The selected LC-QToF or LC-Q-Orbitrap configuration meets the stated performance needs. UHPLC flow, pressure, injection, and carryover parameters have been checked. Mass range, resolution, acquisition speed, accuracy, and sensitivity have been mapped. The 24-hour mass-accuracy evidence is available. Application notes and calibration curves below 5 ppb are available. Honey-authentication data has been included where required. Software licences, libraries and databases have been listed. Workstation and storage configurations have been verified. Gas, vacuum, and UPS systems constitute part of the supply. There are cylinder certificates and gas purity documents. Amounts of accessories have been verified. Training and on-site validation arrangements are confirmed. Warranty, response time, and maintenance arrangements are outlined. Costs of AMC and CMC are listed separately. There are customer testimonials and verified data sheets. All variations from the final tender are noted. Recommended Procurement Practices These are the recommendations, not added legal duties. Define the laboratory's applications before choosing technical specifications. Utilize a clause-wise compliance matrix in each bidding. Demand performance testing of competing systems as a common practice. Allow the use of equivalent technology with verifiable output. Evaluate manufacturer's authorisation and servicing capabilities. Differentiate perpetual software from subscription services. Check laboratory power, gas, cooling and space before tender issue. Calculate lifecycle cost rather than comparing only the purchase price. Record every technical clarification through the formal tender process. Link payment milestones with installation, qualification, training and acceptance. Risks to Avoid While Using the FSSAI Specifications The following drafting and evaluation risks need attention: Treating the indicative notice as a mandatory legal standard. Copying every parameter without a laboratory-needs assessment. Using brand-based wording where performance-based wording is possible. Comparing resolution without stating measurement conditions. Treating Screening Detection Limit and Limit of Quantification as the same measure. Leaving the demonstration protocol open to different interpretations. Ignoring software subscriptions and database renewal charges. Accepting a long warranty promise without manufacturer backing. Failing to define service-response and downtime calculations. Ignoring duplication or unclear quantities in the accessory list. Business Opportunities Created The specifications may support demand for several document-related products and services. LC-QToF and LC-Q-Orbitrap equipment supply. UHPLC systems and compatible columns. Pesticide and antibiotic residue-testing solutions. Honey-authentication methods. Metabolomics and lipidomics software. Spectral databases and laboratory data systems. Nitrogen generation and laboratory gas equipment. UPS installation and power-quality services. Instrument qualification and performance verification. Analyst training and method-development support. AMC, CMC and spare-part supply. Laboratory setup consultancy. Technical tender support and bid-document review. The notice does not announce a procurement quantity or market size. Commercial opportunities will depend on future tenders and individual laboratory decisions. How Can Corpseed Help? Corpseed can support laboratories, procuring organisations, equipment manufacturers and suppliers with document-specific technical tender support. Relevant assistance may include: Reviewing the applicability of the FSSAI benchmark. Preparing a clause-wise compliance matrix. Providing technical bid consulting. Conducting a tender specification review. Identifying unclear or restrictive tender conditions. Bid compliance evaluation. Review of technical data sheets and performance proofs. Warranty, training, and service obligations mapping. Procurement advisory and laboratory establishment planning support. Corpseed focuses on accurate document review and practical bid preparation. Final technical acceptance, procurement and contract decisions remain with the concerned authority. For an LC-HRMS tender or technical bid, Corpseed's technical tender support can help organise requirements, supporting records, deviations and lifecycle commitments before submission. This is an indicative reference to get a fully-fledged LC-HRMS system. The standard includes analytical workflow, instrument capabilities, software, databases, utilities, accessories, training, test data, and support. No statutory purchase duty, registration requirement, compliance deadline, or penalty has been introduced. The final tender issued by the concerned procuring agency will determine the binding technical and commercial conditions. For free consultation, connect with Corpseed!

Subject

Summary: The Ministry of Environment, Forest and Climate Change (MoEFCC) has proposed an amendment to the Environment Impact Assessment (EIA) Notification, 2006, to raise the Environmental Clearance (EC) appraisal threshold for non-coal mining projects from 250 hectares to 500 hectares. The proposed change is intended to further decentralise the EC process by bringing eligible non-coal mining projects with lease areas up to 500 hectares under the State-level appraisal framework. The Ministry has cited the experience of State Environment Impact Assessment Authorities (SEIAAs), the availability of qualified experts through State Expert Appraisal Committees (SEACs), the online EC process through the PARIVESH portal, and the existing 500-hectare delegation for coal mining projects.  The proposal is currently at the draft stage and is not yet an effective change. The notification provides 60 days for interested persons to submit objections or suggestions before the Central Government considers the proposal. Businesses involved in non-coal mining should track the final notification and assess how the proposed threshold could affect their Environmental Clearance process. Effective Date and Current Status of the Draft Amendment The proposed amendment is currently at the draft stage. The key points regarding its status are: Current status: Draft notification is not a final amendment.  Proposed change: Increase the non-coal mining EC appraisal threshold from 250 hectares to 500 hectares.  Consultation period: The draft will be considered after 60 days from the date copies of the Gazette containing the notification are made available to the public.  Objections and suggestions: Interested persons may submit their objections or suggestions to the Secretary, Ministry of Environment, Forest and Climate Change during the specified period.  Effective date: The shared notification does not specify a final effective date for the proposed 500-hectare threshold.  Current compliance position: Businesses should continue following the applicable provisions currently in force until the amendment is formally finalised and notified. What Is the Proposed Amendment? The central change relates to Item 1(a) in the Schedule to the EIA Notification, 2006. The draft proposes the following changes: Existing provision Proposed provision Projects with lease area >250 hectares Projects with lease area >500 hectares Projects with lease area ≤250 hectares Projects with lease area ≤500 hectares In simple terms, the proposal would increase the threshold from 250 hectares to 500 hectares. The proposed amendment is intended to shift the appraisal responsibility for a larger group of non-coal mining projects towards the State-level Environmental Clearance mechanism. This is primarily an administrative and appraisal-level change. It should not be interpreted as an exemption from Environmental Clearance or other environmental obligations. The requirement to comply with the applicable environmental laws, conditions and regulatory requirements would continue to apply to projects covered by the EIA framework. Background of the EIA Notification, 2006 The proposed amendment is linked to the Environment Impact Assessment (EIA) Notification, 2006 issued on 14 September 2006. The notification requires prior Environmental Clearance for specified projects and activities listed in its Schedule. For State-level implementation, State Environment Impact Assessment Authorities (SEIAAs) were constituted under Section 3(3) of the Environment (Protection) Act, 1986. These authorities exercise delegated powers to consider and grant EC for applicable Category B projects. The draft also notes that: Environmental Clearance for minor mineral mining projects, irrespective of mine lease area, has been delegated to the SEIAA level.  Regulation of mining activities, including prevention of illegal mining, primarily falls under the respective State Governments.  Such mining regulation operates under the Mines and Minerals (Development and Regulation) Act, 1957 (MMDR Act) and the rules made under it.  SEIAAs have gained substantial experience in EC appraisal over the past two decades.  The State-level EC process has been made completely online through the PARIVESH portal.  This existing State-level framework forms the basis for MoEFCC's proposal to further decentralise EC appraisal for non-coal mining projects. Why Has MoEFCC Proposed Raising the Threshold to 500 Hectares? MoEFCC has proposed the increase after considering the experience and capacity already available at the State level. The Ministry has noted that SEIAAs have handled Environmental Clearance appraisals for around two decades, while the State-level process is now fully online through the PARIVESH portal. The draft notification highlights the following reasons for raising the threshold: State-level experience: SEIAAs have gained substantial experience in the EC appraisal process. Qualified experts: The eligibility criteria for experts nominated to EACs and SEACs are identical and governed by Appendix VI of the EIA Notification, 2006. Online processing: The PARIVESH portal has made the State-level EC process completely online for more efficient and transparent disposal. Existing coal mining framework: States have already been delegated powers to appraise coal mining projects up to 500 hectares. Request from the Ministry of Mines: The Ministry of Mines has requested similar delegation for non-coal mining projects with lease areas up to 500 hectares. Further decentralisation: MoEFCC considers raising the threshold from 250 to 500 hectares appropriate for facilitating EC appraisal at the State level. What Does the Amendment Mean for the Appraisal Authority? The proposed amendment is mainly about where eligible non-coal mining projects are appraised for Environmental Clearance. MoEFCC proposes to extend the State-level appraisal framework to non-coal mining projects with lease areas up to 500 hectares. Under the proposed framework: SEIAA: State Environment Impact Assessment Authorities would handle the Environmental Clearance process for eligible projects at the State level. SEAC: State Expert Appraisal Committees would assist SEIAAs by carrying out the required technical appraisal. Projects up to 500 Hectares: Non-coal mining projects falling within the proposed threshold could be considered through the State-level mechanism if the amendment is finalised. Greater Decentralisation: The proposal would move a wider range of non-coal mining EC proposals to the State level instead of retaining the existing 250-hectare threshold. No Automatic Exemption: The change concerns the appraisal authority and threshold. It does not by itself remove the Environmental Clearance requirement, or other applicable environmental and mining obligations. The proposed approach is based on MoEFCC's view that SEIAAs and SEACs have gained sufficient experience and expertise to handle a wider range of non-coal mining proposals at the State level. How Will the Proposed Amendment Affect Non-Coal Mining Projects? The proposed change is particularly relevant to non-coal mining projects with lease areas between 250 hectares and 500 hectares. If the amendment is finalised in its proposed form, these projects could come under the State-level Environmental Clearance appraisal mechanism. The expected impact includes: Greater State-level Involvement: Eligible projects could be appraised through SEIAA and SEAC. Wider State-level Coverage: More non-coal mining projects could fall within the State-level appraisal framework. Change in Appraisal Authority: Projects currently falling above the 250-hectare threshold may see a change in the level at which their EC proposals are considered. Potential Process Efficiency: Decentralisation may support more efficient handling of eligible proposals, although it does not guarantee faster Environmental Clearance. Continued Compliance: Project proponents would still need to meet applicable EC requirements, environmental conditions and other mining-related obligations. What Are the Expected Benefits of the Proposed Amendment? If the proposal is finalised substantially as drafted, the increase in the threshold could provide a more decentralised approach to Environmental Clearance appraisal for eligible non-coal mining projects. The key expected benefits include: Greater State-level role: More eligible projects could be handled through State-level authorities.  Expanded role of SEACs: SEACs could receive a wider range of non-coal mining proposals for technical appraisal.  Reduced Central-level burden: Some projects could move away from the Central-level appraisal mechanism.  Potentially smoother coordination: Project proponents may have greater interaction with authorities at the State level.  Better alignment: The proposed 500-hectare threshold would align non-coal mining with the existing delegation referred to for coal mining projects.  These benefits should be viewed as potential outcomes, rather than guaranteed improvements in approval timelines. The quality of project submissions and compliance with appraisal requirements will continue to influence the overall process.  What Does the Proposed Change Mean for Environmental Clearance Compliance? The proposed amendment changes the appraisal threshold, but it does not mean that non-coal mining projects up to 500 hectares will automatically be exempt from Environmental Clearance. Project proponents will still need to determine whether their activities fall within the applicable entries of the EIA Notification, 2006 and follow the requirements that apply to their projects. Businesses should keep the following compliance areas separate: Environmental Clearance requirement Authority responsible for appraisal Project category Lease-area threshold Conditions attached to the EC Other mining and environmental permissions The draft also makes it clear that mining regulation is not limited to the EC framework. Requirements under the Mines and Minerals (Development and Regulation) Act, 1957 (MMDR Act) and applicable State rules must also be considered. Therefore, a change in the EC appraisal mechanism should not be treated as a replacement for other mining approvals or regulatory obligations. Environmental and Operational Compliance Considerations Even if the threshold is increased to 500 hectares, mining businesses will continue to deal with environmental impacts arising from their operations. Depending on the project, compliance planning may need to address: Land disturbance and soil management Air emissions and dust Water consumption and water resources Waste generation Biodiversity Noise and vibration Transportation-related impacts Rehabilitation and restoration of mined areas Impacts on surrounding communities The proposed change in the appraisal threshold does not remove the responsibility of project proponents to comply with the conditions attached to their Environmental Clearance. Businesses should treat EC compliance as an ongoing responsibility, rather than a one-time approval requirement. What Should Businesses Do Now? Since the proposal is still at the draft stage, businesses should focus on monitoring, reviewing and preparing rather than immediately changing their compliance strategy. Track the final notification: Monitor further updates from MoEFCC, and review the final wording before relying on the proposed 500-hectare threshold. Review lease areas: Identify current and proposed non-coal mining projects falling between 250 and 500 hectares as these are likely to be most directly affected. Review EC applications: Businesses with applications under preparation or already in process should assess their position, but should not automatically change their strategy based only on the draft. Keep documentation updated: Maintain project details, mining lease information, mining plans, environmental studies, land records, existing approvals and EC-related documents. Review other approvals: Map the project's requirements under applicable mining laws, environmental regulations and State-level rules separately from the EC appraisal process. Monitor State-level procedures: If finalised, the proposal could increase the role of State-level authorities in appraising eligible non-coal mining projects. Consider submitting comments: Businesses and other affected stakeholders can review the draft and consider submitting objections or suggestions within the prescribed consultation period. Public Consultation and 60-Day Objection Period The draft notification provides stakeholders with an opportunity to submit their objections or suggestions before the Central Government considers the proposed amendment. The notification states that the draft will be taken into consideration after 60 days from the date on which copies of the Gazette containing the notification are made available to the public. Interested persons may submit their views in writing to the Secretary, Ministry of Environment, Forest and Climate Change within the specified period. The consultation process is important because the current proposal is not the final amendment. Businesses and other stakeholders should distinguish the regulatory process as follows: Draft notification - 60-day consultation period - Consideration by Central Government - Final notification Until the amendment is formally finalised and notified, businesses should not treat the proposed 500-hectare threshold as the operative requirement.  Compliance Checklist for Non-Coal Mining Companies Businesses can use the following checklist while monitoring the proposed amendment: Compliance Area Action Project category Confirm whether the project falls under the relevant mining category Lease area Verify the total lease area and identify projects between 250 and 500 hectares EC requirement Confirm whether prior Environmental Clearance is required Appraisal authority Check the authority applicable under the prevailing notification Draft amendment Track the status of the proposed 500-hectare threshold Documentation Keep project and environmental records updated PARIVESH Maintain consistency in information submitted through the online system Mining approvals Separately review requirements under applicable mining laws State regulations Check relevant State-level mining and environmental requirements State regulations Continue monitoring and complying with existing EC conditions Public consultation Consider submitting comments if the proposal affects the business Final notification Review the final amendment before changing compliance strategy Who Should Closely Monitor This Amendment? The proposal is particularly relevant to: Non-coal mining companies Mining lease holders Companies planning new non-coal mining projects Mineral extraction businesses Mining project developers Environmental consultants Regulatory compliance teams Legal and corporate affairs teams handling mining approvals Industry associations State-level mining stakeholders Businesses with projects between 250 and 500 hectares How Can Corpseed Help? Keeping up with Environmental Clearance requirements can be difficult for mining businesses, especially when proposed regulatory changes may affect how projects are appraised. The proposed increase in the non-coal mining threshold makes it important for businesses to understand their present compliance position while monitoring the final regulatory outcome.  Corpseed supports businesses with practical regulatory guidance to help them assess project requirements, manage documentation and stay prepared for changes in the Environmental Clearance framework. Our Services Include: EC Requirement Assessment: Reviewing the nature, category and lease area of a mining project to identify the Environmental Clearance requirements applicable under the current framework. Compliance Documentation: Helping businesses organise and review the project information, environmental records and supporting documents required for regulatory submissions. Mining Compliance Advisory: Guiding the environmental and mining-related approvals that may apply alongside the Environmental Clearance process. Project Compliance Review: Assessing existing and proposed projects to identify areas that may require attention, particularly where the lease area falls within the proposed 250-500 hectare range. Regulatory Change Support: Helping businesses understand the practical implications of the proposed EIA amendment and prepare for the final regulatory position. PARIVESH Support: Assisting with the review of information and documentation required for online Environmental Clearance processing through the PARIVESH portal. Compliance Gap Identification: Reviewing current compliance practices to identify potential gaps and providing practical recommendations for addressing them. Ongoing Regulatory Assistance: Supporting businesses with continued compliance guidance and regulatory monitoring as Environmental Clearance requirements and related provisions evolve. Compliance Action: Mining companies should track the final MoEFCC notification, review projects falling within the 250-500 hectare range, assess the impact on their Environmental Clearance strategy and update their compliance approach once the amendment is officially finalised.

Subject

Summary: The Central Drugs Standard Control Organisation has issued an important clarification on compliance regarding applications filed under Rule 4 of the Drugs and Cosmetics (Compounding of Offences) Rules, 2025. According to the CDSCO circular dated 21 July 2026, it is also made clear that, to apply for compounding of any offence, the application must be made to the competent authority having jurisdiction over such offence. This clarification was needed because, in many cases, the Central Compounding Authority was receiving applications within the jurisdiction of the State/Union Territory Drug Control Administration. This circular directly impacts all individuals and companies engaged in the manufacture, import, dealing in, distribution, wholesale dealing, marketing, and licensing of drugs and cosmetics, as per the Drugs and Cosmetics Act, 1940. The point to note is that, simply because CDSCO is the central drug regulatory body, an application to compound the offence cannot be made to the Central Authority. First, the company in question needs to know who took the sample and which licensing authority has jurisdiction over the matter. An application filed before an authority without jurisdiction may be returned or rejected. This can increase regulatory costs, delay case closure and prolong uncertainty around licences, commercial transactions and business operations. Importantly, the July 2026 circular does not create a new compounding law. It clarifies how the existing Rule 4 filing mechanism must be used. CDSCO Circular at a Glance Particular Details Issuing authority Central Drugs Standard Control Organisation Administrative department Directorate General of Health Services, Government of India Circular date 21 July 2026 CDSCO release date 22 July 2026 Subject Clarification regarding submission of applications under Rule 4 Applicable framework Drugs and Cosmetics (Compounding of Offences) Rules, 2025 Stakeholders covered Manufacturers, importers, distributors, licence holders and other applicants Main requirement Application must be filed before the competent compounding authority having jurisdiction Central jurisdiction Sample drawn by a CDSCO Drugs Inspector or offence concerning the Central Licensing Authority State jurisdiction Sample drawn by a State/UT Drugs Inspector and offence falling under the State/UT Drugs Licensing Authority Risk of filing before the wrong authority Application may be returned or rejected, requiring refiling before the competent authority What Is Compounding of an Offence? Compounding is an administrative procedure that allows certain offences to be handled without going through the entire criminal process, upon payment of the amount set by the concerned authorities and adherence to the stipulated conditions. In practical terms, it allows an eligible company or individual to approach the designated compounding authority, disclose the facts of the case, submit the prescribed application and request that the offence be compounded. The authority may examine the application, obtain a report from the relevant licensing or reporting authority, hear the applicant and decide whether the case should be compounded. If the application is accepted, the authority specifies the compounding amount and may grant immunity from prosecution subject to conditions. Compounding should not be confused with: Automatic payment of a regulatory penalty, An out-of-court private settlement, Withdrawal of every regulatory action against the applicant, Cancellation of inspection findings, Automatic protection of a drug or cosmetic licence, or A general waiver covering all past or related violations. It is a formal statutory proceeding available only for eligible offences and only with the competent authority's permission. Is compounding available as a right? No. Compounding of offences is not an absolute right of an individual. The application form for compounding of offences explicitly mentions that compounding cannot be claimed as a right by the applicant. The authority takes into account the type of offence, the applicant's disclosures, the applicant's cooperation in the case, relevant documentation, and the regulatory authority's report. Background of the Compounding Framework The Drugs and Cosmetics Act, 1940 The Drugs and Cosmetics Act, 1940 regulates the import, manufacture, distribution and sale of drugs and cosmetics in India. It establishes requirements for quality, safety, licensing, labelling, record-keeping, and enforcement for regulated businesses. The Act works through the regulatory framework at both Central and State levels. The CDSCO and the Central Licensing Authority perform certain roles at the Central level, including those concerning important imports and products under central regulation. The State and UT Drug Control Authorities handle other roles. This division of authority is one of the main reasons why businesses must carefully determine jurisdiction before filing a compounding application. Section 32B of the Drugs and Cosmetics Act Section 32B provides the statutory basis for compounding specified offences. It permits eligible offences to be compounded either before or after the institution of prosecution, subject to the statutory restrictions and prescribed procedure. The section also provides that: Only specified offences can be considered, The Central Government, State Government or an authorised officer may undertake compounding, The compounding amount cannot exceed the applicable statutory limit, A subsequent offence is not compoundable, Court permission may be required where the accused has been committed for trial or has been convicted, and an appeal is pending, and Once an offence is validly compounded, further proceedings concerning that compounded offence are restricted in accordance with the Act. The complete statutory eligibility conditions must be examined before preparing an application. Jan Vishwas (Amendment of Provisions) Act, 2023 The Jan Vishwas (Amendment of Provisions) Act, 2023 was introduced to rationalise regulatory offences, support trust-based governance, and promote ease of doing business. Among other amendments, it expanded the provisions referenced in Section 32B of the Drugs and Cosmetics Act. The relevant amendments became effective on 31 December 2024. The objective was not to weaken drug-quality regulation. It was to create a structured method for resolving eligible regulatory contraventions while allowing serious public-health violations to continue under the stricter prosecution framework. Drugs and Cosmetics (Compounding of Offences) Rules, 2025 The Ministry of Health and Family Welfare notified the Drugs and Cosmetics (Compounding of Offences) Rules, 2025 through G.S.R. 259(E) dated 24 April 2025. The Rules prescribe: Appointment of compounding authorities, Form and manner of application, Information and documents to be submitted, Procedure for obtaining the reporting authority's comments, Decision-making process, Payment of the compounding amount, Grant of immunity from prosecution, and Withdrawal of immunity in specified circumstances. Appointment of the Central Compounding Authority The Central Government appointed the Additional Director General of Health Services, who deals with CDSCO matters, as the Central Compounding Authority. The appointment authorises the officer to exercise the Central Government's powers and functions in relation to the compounding of eligible offences.  Legal and Regulatory Timeline Date Regulatory development Business significance 11 August 2023 Jan Vishwas Act received presidential assent Introduced a wider decriminalisation and trust-based compliance framework 31 December 2024 Relevant Drugs and Cosmetics Act amendments became effective Expanded the statutory compounding framework 24 April 2025 G.S.R. 259(E) notified Compounding of Offences Rules became operational 1 August 2025 S.O. 3551(E) issued Central Compounding Authority was appointed 2025–2026 CDSCO issued guidance, procedural material and FAQs Application requirements and regulatory process were explained 21 July 2026 CDSCO jurisdiction clarification issued Correct Central-versus-State filing position was clarified 22 July 2026 Circular published on the CDSCO website Clarification became publicly available to regulated stakeholders Why Did CDSCO Issue the 2026 Clarification? Applications were being filed before the wrong authority CDSCO observed that applications were being submitted to the Central Compounding Authority even when the sample had been drawn by a State or UT Drugs Inspector and the alleged offence fell under the jurisdiction of the State or UT Drugs Licensing Authority. Such applications create a jurisdictional problem. An authority must have legal competence over the alleged offence before it can process and decide the request. India follows a dual regulatory structure. Drug and cosmetic regulation in India is divided between Central and State authorities. A company may hold different licences for manufacturing, importing, selling or distributing regulated products, with different authorities controlling different parts of the business. A single company may therefore have: State manufacturing licences, Central import registrations, Medical-device permissions, Cosmetic import registrations, Wholesale or sale licences, and Multiple facilities operating across States. This regulatory structure makes it unsafe to select the compounding authority only based on the applicant's registered office or corporate location. Incorrect filing causes delay and additional cost. When an application is submitted to the wrong authority, it may have to be returned, rejected, or resubmitted. The business may then face: Duplicate professional and documentation expenses, Additional regulatory communication, Duplicate internal authorizations, Extended resolution times for cases, Uncertainty regarding prosecution, and Increased pharmaceutical legal compliance costs. For companies facing regulatory due diligence, investment, licence renewal or a business acquisition, an unresolved enforcement proceeding can also become a significant commercial concern. Uniform implementation was required. The circular creates a common principle for applicants and regulators: determine the authority connected with the sample, alleged offence and licensing jurisdiction before submitting the Rule 4 application. What Has Changed? The circular clarifies the filing forum for Rule 4 applications. The following position must now be followed clearly: A State or UT matter should be filed before the concerned State or UT Compounding Authority, A matter arising from sampling by a CDSCO Drugs Inspector should be filed before the Central Compounding Authority, A matter falling under the Central Licensing Authority should be filed before the Central Compounding Authority, and An application filed before an authority without jurisdiction is liable to be returned or rejected. The clarification places greater responsibility on applicants and their CDSCO compliance consultants to perform a jurisdiction assessment before filing. What Has Not Changed? The circular does not: Introduce a new compounding law, Replace the 2025 Rules, Create a new prescribed application form, Expand the statutory list of compoundable offences, Make every drug, cosmetic or medical-device violation compoundable, Establish a compounding amount that is universally applied, Ensure acceptance of the application, Offer automatic exemption from prosecution, Discontinue the need for honest disclosure, End the involvement of the reporting authority, Establish a new process of appeal, Automatic closure of other proceedings, or Automatic protection of the licence from suspension or cancellation proceedings. This is an important difference to make. The 2026 circular is a jurisdictional compliance notice, not a new compounding scheme. Who Is Affected? Drug manufacturers The companies under inspection, test report, show cause notice, or investigation for prosecution shall ascertain whether a State Drugs Inspector or a CDSCO officer initiated the case. Pharmaceutical importers Issues related to import tend to be Central in nature. Nevertheless, firms should investigate whether the licence, officer, breach, and enforcing authority have Central jurisdiction. Cosmetic manufacturers and importers Firms in the cosmetic sector shall determine whether the violation issue falls under State or Central jurisdiction. Medical-device and IVD businesses Medical devices notified as drugs may fall within the wider Drugs and Cosmetics regulatory framework. However, eligibility for compounding and the appropriate authority must be assessed on a case-by-case basis, based on the specific offence and licensing facts. Distributors, stockists and wholesalers Distributors and wholesalers may face allegations relating to storage, sale, records, disclosure of the product source or distribution of non-compliant products. The relevant State or Central authority will depend on the facts of the proceeding. Marketing companies and licence holders Marketing authorisation holders and businesses that market products manufactured by third parties must review whether they are separately named or implicated in the case. Directors and responsible officers Section 32B refers to eligible offences committed by companies or their officers. Separate applications may be required for different persons or entities, depending on how the proceeding was initiated. Which Offences Can Be Considered for Compounding? Section 32B refers to specified provisions of the Drugs and Cosmetics Act. Their broad nature is set out below, but actual eligibility must be determined from the current statutory language, charge and facts. Legal provision Broad subject Important eligibility consideration Section 13(1)(b) Certain prohibited import contraventions not falling within the more serious category under Section 13(1)(a) Generally connected with Central import jurisdiction, but exact facts must be verified Section 27(d) Drug-related contraventions not covered by the more serious categories in Sections 27(a), 27(b) or 27(c) Exact charge and statutory conditions require legal examination Section 27A(ii) Certain cosmetic contraventions other than the more serious spurious or adulterated cosmetic category Central or State jurisdiction depends on licensing and enforcement facts Section 28 Failure to disclose specified manufacturer or source particulars Authority depends on the inspector and underlying regulatory proceeding Section 28A Failure to maintain prescribed records or furnish required information without reasonable cause Licensing and inspection jurisdiction must be examined Just because a number exists in Section 32B does not imply that all cases filed under this section can be compounded. All statutory requirements need to be satisfied by the applicant. Statutory limitations A business needs to know whether: The specific offence falls within Section 32B, Compounding of such offences is possible through the statutory punishment scheme, It is a first-time offence, There is an issue of conviction or a subsequent offence, Prosecution of the offence has begun, The accused has been committed for trial, Conviction has taken place, and an appeal is pending, Permission from the court is needed, There have been full and frank disclosures on the part of the applicant, and Other proceedings exist under another statute. Serious offences involving spurious, adulterated or harmful products should never be assumed to be compoundable without a detailed pharmaceutical regulatory and legal assessment. Rule 4 Explained: Form and Manner of Application Rule 4 governs how an application for compounding must be made. When can the application be submitted? An application may be made either before or after the institution of prosecution. However, the stage of the case matters. If the accused has already been committed for trial, or has been convicted and an appeal is pending, court permission may be necessary under Section 32B. Who can apply? A company or individual involved in the manufacture, import, sale, distribution or another regulated activity may apply in respect of an eligible offence. Where multiple entities or individuals are involved, each applicant may need to submit an individual application. A company should not assume that its application automatically covers its directors, responsible officers, marketers or distributors. Which form must be used? The application must be submitted in the prescribed form appended to the Rules, along with relevant supporting documents. What must the applicant declare? The applicant must: Agree to pay the amount determined by the compounding authority, Acknowledge that compounding cannot be demanded as a right, Confirm that the information provided is true, Confirm that no material fact has been suppressed, Verify the authenticity of accompanying documents, and Establish the signatory's authority and competence to submit the application. How to Determine the Correct Compounding Authority Correct jurisdiction is now the most important pre-filing step. Step 1: Identify who drew the sample Review the sampling documents and establish whether the sample was drawn by: A Drugs Inspector appointed by a State or UT Government, or A CDSCO Drugs Inspector. The circular specifically links the competent authority to the authority that drew the sample. Step 2: Identification of Licensing Authority The applicant should find out whether the licence and regulated activities related to the alleged offence are governed by: State/UT Drugs Licensing Authority or Central Licensing Authority. Step 3: Identification of Subject Matter of Alleged Offence The applicant should consider whether the subject matter of the alleged offence relates to: Manufacture, Import, Sale/Distribution, Product Quality, Labeling, Disclosure of the manufacturer or source, Licence conditions, or Another regulated activity. Step 4: Review the enforcement documents The following documents can help establish jurisdiction: Sample-drawing form, Inspection report, Test or analysis report, Show-cause notice, Seizure memo, Complaint or charge sheet, Manufacturing licence, Import licence, Registration certificate, Correspondence with CDSCO or the State authority, and Details of the officer who initiated the proceeding. Step 5: Verify the designated authority Businesses should confirm that the relevant Central or State compounding authority has been appointed and obtain the latest filing instructions. If a State or UT process is unclear, the applicant should seek a written or professional assessment of jurisdiction. It should not automatically redirect the matter to the Central Authority. Central vs State Jurisdiction Matrix Regulatory situation Competent authority Sample drawn by a State/UT Drugs Inspector and offence falls under State/UT Licensing Authority Concerned State/UT Compounding Authority Sample drawn by a CDSCO Drugs Inspector Central Compounding Authority Alleged offence concerns a Central Licensing Authority matter Central Compounding Authority State officer drew the sample, and the matter is entirely State-licensed State/UT Compounding Authority Case involves Central and State licences or multiple inspecting authorities Detailed jurisdiction assessment required before filing Identity of the sample-drawing officer is unclear Review original sampling, inspection and enforcement records Application has already been filed before an authority without jurisdiction It may be returned or rejected, the applicant may have to refile Applicant’s head office is in one State but offence occurred elsewhere Jurisdiction should be based on the offence, inspector and licensing authority, not merely the head-office location Application has already been filed before an authority without jurisdiction. It may be returned or rejected; the applicant may have to refile     Effective Date and Implementation Requirements The Compounding of Offences Rules were promulgated on 24 April 2025. The clarifications regarding the jurisdiction were released on 21 July 2026. As the circular provides no future implementation date, firms planning to file new applications must strictly abide by the jurisdictional stance as clarified immediately. Companies with applications already pending before an authority should review whether the chosen authority has jurisdiction. Where an application appears to have been filed incorrectly, the company should obtain professional advice before withdrawing, amending or refiling it. Documents Required for a Rule 4 Compounding Application The official CDSCO guidance contains the application checklist and the administrative process flow. Document category Documents and information Applicant information Name, registered address, communication address and contact details Corporate authorisation Board resolution, power of attorney or authorisation of the signatory Product details Product name, composition, manufacturer, importer and marketer information Regulatory permissions Manufacturing licence, import licence, registration certificate and applicable approvals Import documentation Import Export Code and relevant import records, where applicable Quality documentation Manufacturer’s Certificate of Analysis or report from an NABL-accredited laboratory, where relevant Sampling documents Applicable sample-drawing forms, including Form 17, COS-10 or MD-36 Test reports Applicable reports such as Form 13, Form 2, COS-14, COS-21, MD-31 or MD-32 Enforcement documents Inspection report, show-cause notice, seizure memo, charge sheet or complaint Offence particulars Provisions allegedly contravened, date, location and brief facts Case status Whether prosecution is contemplated, instituted, at trial or under appeal Previous proceedings Details of earlier offences, convictions or regulatory proceedings Other laws Details of proceedings concerning the same conduct under any other law Applicant’s declaration Agreement to pay and acknowledgement that compounding is not a legal right Verification Confirmation of truthfulness, completeness and non-suppression of facts Step-by-Step Compliance Process 1. Examine the alleged offence Identify the exact section invoked in the show-cause notice, complaint, test report, or prosecution document. Do not describe the matter as compoundable until the current statutory provision and Section 32B conditions have been reviewed. 2. Determine first-offence status Determine whether the company or the concerned officer was previously convicted of the same offence or any other relevant offence. The offence is not compoundable as per Section 32B. 3. Find out at what stage the proceeding is at Ascertain if the proceeding is at: The stage of filing of prosecution, A complaint has been lodged, Committed to trial, A trial is ongoing, or an appeal is pending. This determines whether additional court permission may be necessary. 4. Conduct a jurisdiction assessment Identify: Who selected the sample, Who served the notice, By which body was the licence issued, Where the alleged offence was committed, Is it a Central or State issue, and Which compounding authority is legally empowered to do so. 5. Prepare the prescribed form Complete every applicable field. Where a field is not applicable, clearly mark it as not applicable instead of leaving it unexplained. 6. Compile supporting documents It is required to gather and organise all documents which include: Licenses, Approvals for products, Laboratory papers, Sampling papers, Inspection papers, Show-cause notices, Legal papers, and Authorisations by the corporation. 7. Prepare the factual statement The factual submission should explain: What happened, When and where it happened, The applicant's role, The alleged violation, The present status of proceedings, Corrective action taken, Preventive measures implemented, and Why the application satisfies the statutory conditions. The statement should be transparent and consistent with every document already submitted to the regulator or court. 8. Submit before the competent authority Follow the latest filing mode prescribed by the concerned Central or State authority. The filing instructions applicable to the Central Compounding Authority should not automatically be used for a State application. 9. Respond to regulatory queries The authority may request explanations, documents or additional information. Responses should be accurate, complete and filed within the allowed period. 10. Prepare for the hearing If a hearing is scheduled, the applicant should prepare: A concise chronology, Legal eligibility submissions, Technical and quality explanations, Corrective-action evidence, Licence and inspection records, and Responses to the reporting authority's observations. 11. Comply with the order If the application is allowed, the applicant must pay the specified amount within the prescribed time and furnish proof of payment. 12. Monitor immunity conditions The applicant should maintain a written record of every condition and track continuing compliance. What Happens After Filing? Once an application is received, the compounding authority seeks a report from the reporting authority having jurisdiction over the alleged offence. The reporting authority is generally the relevant licensing authority, the Central Licensing Authority, or the Central Licence Approving Authority connected with the place where the offence was committed or allegedly committed. After reviewing the application and report, the compounding authority may: Allow the application, Specify the compounding amount, Grant immunity subject to conditions, or Reject the application. Before rejecting an application, the applicant must be given a hearing, and the grounds for rejection must be recorded. Every order must be communicated to the applicant. Procedural Timelines Stage Responsible person or authority Timeline Submission of application Applicant Before or after institution of prosecution Calling for factual report Compounding Authority After receiving the application Submission of report Reporting Authority Generally within one month, subject to permitted extension Internal request to the relevant CDSCO office in a Central case Reporting Authority CDSCO guidance describes an internal five-day step Internal report by the concerned zonal, sub-zonal or port office Concerned CDSCO office CDSCO guidance describes an internal ten-day step Opportunity of hearing Compounding Authority Before rejection Payment of compounding amount Applicant Within 30 days of receiving the order Submission of payment proof Applicant Within the prescribed payment period Continuing compliance Applicant Throughout the period of any conditions imposed The compounding authority may extend the one-month reporting period. Businesses should therefore treat it as a statutory procedural benchmark, not a guaranteed final-disposal date. Grounds for Return, Rejection or Delay A Rule 4 application may face difficulty because of: Filing before an authority without jurisdiction, Incorrect identification of the sample-drawing inspector, Failure to establish statutory eligibility, Incomplete prescribed form, Missing licences or product approvals, Inconsistent dates or factual submissions, Failure to disclose previous proceedings, Missing prosecution or court documents, Absence of proper corporate authorisation, Joint filing where individual applications are required, Suppression of material information, False or misleading evidence, Failure to answer regulatory queries, Lack of supporting corrective-action records, or Failure to obtain court permission where required. A jurisdictional return should be distinguished from a rejection on the merits. If an application is returned because it was submitted to the wrong authority, that does not necessarily mean the underlying offence is ineligible. However, the applicant must still correct the filing and independently establish eligibility before the proper authority. Compounding Amount and Payment Obligations The compounding authority determines the amount after considering the application, case facts, and reporting authority's comments. Businesses should not assume there is a single standard CDSCO compounding fee applicable to every case. The amount depends on the legal provision and facts, subject to the statutory ceiling. Once an order allowing compounding is received, the applicant must generally: Pay the specified amount within 30 days, Credit the amount as directed, Preserve the payment record, and Furnish proof to the compounding authority. The amount is generally non-refundable. The Rules recognise a limited exception where the court rejects the grant of immunity. Failure to pay within the required period can result in withdrawal of immunity and continuation of prosecution. Immunity from Prosecution The compounding authority may grant immunity when satisfied that the applicant has: Cooperated during the proceedings, Made a full and true disclosure, Submitted the required information, and Complied with the conditions of the compounding order. Immunity is case-specific. It does not necessarily protect the applicant from: Unrelated offences, Proceedings under another law, Future contraventions, Separate licence suspension or cancellation, Product recall or corrective action, Civil or contractual claims, or Action arising from information that was concealed. Withdrawal of immunity Immunity may be withdrawn where the applicant: Fails to pay the compounding amount, Fails to comply with an imposed condition, Conceals a material fact, Gives false evidence, or Makes an incomplete or misleading disclosure. Once immunity is withdrawn, the applicant may be prosecuted as if the immunity had never been granted. This makes document accuracy and legal review critical. A poorly prepared application can create greater risk if it contains inconsistent statements or incomplete disclosures. Impact on Pharmaceutical, Cosmetic and Medical-Device Businesses Business area Compliance impact Regulatory strategy Jurisdiction assessment becomes a mandatory practical pre-filing exercise. Application cost Correct filing can prevent duplicate professional and documentation expenses. Case timelines Wrong filing can result in return, rejection, and refiling delays. Legal exposure Compounding remains discretionary and subject to statutory eligibility. Licence management Separate licensing proceedings may continue despite compounding. Documentation Sampling, inspection, testing and prosecution records must be traceable Management time Legal, regulatory, quality and senior-management teams must coordinate Transaction readiness Pending proceedings may affect investor, lender or acquisition due diligence. Business reputation Transparent and timely resolution may demonstrate responsible compliance conduct. Governance Directors and responsible officers need accurate visibility over pending regulatory cases. Financial and Commercial Consequences of Incorrect Filing The cost of filing before the wrong authority is not limited to the need for a fresh set of documents. Businesses may incur: Additional legal and professional fees, Further legal and professional fees, Re-filing costs for duplicate compounding application, Costs for regulatory consultants, Notarization, attestation, and authorization costs, Time of senior management, Technical evaluation of the application by quality and regulatory departments, Hearing costs and travel, Delay in conclusion of prosecution case, Lengthy period for disclosing information in the due diligence process of investment, and Reputation risk with regulators and investors. A timely jurisdiction assessment by a qualified pharma regulatory consultant in India may therefore reduce the total cost of the proceeding. How Businesses Can Achieve Compliance Immediate compliance actions Companies with pending cases involving regulatory authorities should: Examine all ongoing inspection findings, Identify all show cause notices that have been issued, Determine the section that deals with the alleged offence under Section 32B, Find out whether the case is a first offence, Identify the sampler, Determine which authority issued the license in question, Determine whether it is a matter for Central or State authorities, Determine the designated compounding authority, Identify testing and sampling records, Review the form prescribed, Establish where the prosecution is at, Seek legal opinion on court permission (if required), and Create a consistent application. Long-term compliance controls Businesses should establish: Regulatory case file registry, License to authority map, Jurisdiction matrix for each location, Sample and inspection documents, Prosecution status monitoring, Previous conviction declaration process, Pre-filing legal assessment, Records of corrective and preventative actions, Hearing response process, Conditions for payment and immunity, and Drug license and regulation compliance audits. Common Mistakes Businesses Must Avoid Treating every offence as compoundable Only specified offences can be considered. A legal eligibility review must come before application preparation. Filing every case before CDSCO CDSCO is the national regulatory organisation, but the Central Compounding Authority does not automatically have jurisdiction over State matters. Relying on the company's registered office The location of the head office is not the sole deciding factor. The inspector, offence, licence and regulatory subject matter must be examined. Ignoring the sample-drawing documents The circular gives significant importance to the authority that drew the sample. Confusing the reporting authority with the compounding authority The reporting authority provides the factual regulatory report. The compounding authority decides the application. Previous proceedings suppression Failure to disclose previous offences, prosecutions, or regulatory proceedings will affect eligibility and immunity. Inconsistency in facts used There should be consistency in the facts provided in the Rule 4 application, show-cause responses, licensing applications, lab reports, and pleadings. Thinking that payments settle all matters Payment will not suffice. Evidence must be furnished, compliance undertaken, and separate regulatory proceedings might still be needed. Missing the payment deadline Failure to pay within 30 days may result in the withdrawal of immunity. Benefits for Businesses The compounding process can provide substantial benefits in certain cases: Resolving the issue faster than through lengthy prosecution, Lowering costs incurred on litigation, Lessening the management burden, Ensuring more certainty over the ongoing proceeding, Chance to exhibit remediation measures, Enhancing cooperation with regulators, Improving preparation for due diligence with respect to regulation, Eliminating disruption arising from past technical offenses, Formal resolution of the compounded offense, and Optimization of judicial/regulatory resources. These benefits are subject to approval. No applicant should market or treat compounding as guaranteed immunity. Is the Clarification a Right Decision or an Additional Burden? The circular is broadly a positive administrative clarification because it addresses a genuine filing problem. It can reduce misdirected applications and help Central and State authorities process cases within their respective jurisdictions. However, it also requires businesses to undertake more careful due diligence before filing. Positive outcome Practical concern Clarifies the appropriate filing authority Applicants must perform a detailed jurisdiction assessment. Reduces misdirected applications Mixed Central-State cases may remain complex. Supports faster case processing State-level procedures may not be identical. Promotes uniform regulatory implementation Incorrect classification may still result in a return or rejection. Supports ease of doing business Professional legal and regulatory assistance may be required. Creates a structured alternative for eligible offences Compounding remains discretionary Encourages corrective compliance Immunity may be withdrawn for non-compliance The clarification should not be viewed as a new burden in itself. The underlying responsibility to file before the competent authority already existed. The circular makes that responsibility explicit and warns applicants about the consequences of incorrect filing. From a policy perspective, it is the right decision because it improves administrative clarity without diluting enforcement against serious violations. Business Opportunities Created The clarification is likely to increase demand for specialised regulatory and compliance support. Regulatory jurisdiction assessment Pharmaceutical, cosmetic, and medical-device businesses will need professional assistance to determine whether their matters fall under Central or State jurisdiction. Rule 4 application preparation Demand may grow for compounding application filing services, document review, and structured factual submissions. Pharmaceutical compliance audits Organizations could carry out preventive audits to detect: Gaps in licences, Documentation failures, Labelling problems, Risk of inspection, Quality problems documentation, and Compoundable past cases. Regulatory case-management services Multi-State manufacturers and distributors may require centralised monitoring of notices, hearings, prosecutions, payment deadlines and immunity conditions. Corrective and preventive action support Consultants in quality and regulation can help organizations establish appropriate corrective actions to improve their application and prevent future violations. Regulatory compliance technology The circular creates demand for digital tools that track: Licenses, Inspecting bodies, Samples of documents, Regulatory cases, Judicial proceedings, Application process, and Deadline for payments. Transactional regulatory due diligence Investors, acquirers and lenders may seek specialised pharmaceutical regulatory due diligence to assess whether pending violations are eligible for compounding and whether they could affect a business's value. How Can Corpseed Help? Preparing a Rule 4 application requires more than completing a form. The applicant must establish eligibility, identify the correct authority, organise technical records and maintain consistency across regulatory and legal documents. Corpseed can support pharmaceutical, cosmetic and medical-device businesses through a structured compliance approach. Preliminary eligibility assessment Corpseed can assist with: Reviewing the alleged offence, Identification of relevant statute, Verification of applicability of Section 32B, Assessment of first-time offence, Assessment of the stage of prosecution, and Identification of issues needing legal expertise/court approval. Central-versus-State jurisdiction assessment Our regulatory-support process can help businesses: Identify the sample drawing inspector, Evaluate the sample and inspection papers, Match the license to its issuing authority, Determine whether the matter falls under Central or State control, and Identify the appropriate compounding authority. This service can reduce the risk of an application being returned or rejected for want of jurisdiction. Documentation and application support Corpseed can provide support in: Rule 4 documents checklist, Check of the application form, Corporate authorization documents, License and registration documentation, Samples and testing documentation, Show cause and prosecution documents, Chronology preparation, Records of corrective actions, and Document indexing and organization. Filing and regulatory coordination Subject to the applicable procedure and professional scope, Corpseed can assist with: Coordinate filing before the appropriate authority, Regulatory correspondence tracking, Document requests management, Preparing structured factual responses, Coordinating technical and legal inputs, and Monitoring the progress of the application. Hearing preparation Where a personal hearing is required, Corpseed can help organise: Case chronology, Licence history, Technical explanations, Corrective and preventive action, Supporting evidence, and Responses to regulatory observations. Legal opinions and representation before courts or authorities should be undertaken through appropriately qualified legal professionals where required. Post-order compliance Corpseed can support businesses in: Tracking the payment due within 30 days, Maintaining the payment history, Submitting the payment proof, Maintaining the immunity conditions, Ensure ongoing compliance, and Make a regulatory closure document. Preventive pharmaceutical regulatory compliance services Apart from the application process, Corpseed can provide help in: Drug license compliance services, CDSCO regulatory advisory, Cosmetic compliance services, Medical device regulatory compliance, Documentation audit, License mapping, Labelling and record audit, and Compliance SOPs. Need assistance with a CDSCO Rule 4 compounding application? Get free consultation from Corpseed. We can help assess eligibility, identify the competent authority, organise supporting documents and coordinate the compliance process for pharmaceutical, cosmetic and medical-device businesses.

Subject

Summary: The Bureau of Indian Standards has established eight Indian Standards covering electrical appliances, network access security, metadata registries, and the C++ programming language. All eight standards were established on 24 July 2026. Four of them replace previous editions that will remain valid concurrently until 24 January 2027. For the other four standards, the notification does not identify a previous Indian Standard for withdrawal. For manufacturers, importers and technology businesses, the notification raises an obvious question: does the establishment of these standards make BIS certification immediately mandatory? The short answer is no-not by this notification alone. Establishing an Indian Standard and making it compulsory are two distinct regulatory actions. A separate Quality Control Order, legislation, government direction, certification condition, tender or contract may be required to make compliance mandatory. Therefore, businesses should not rush into a BIS licence application without first determining: Whether the standard applies to their product or activity, Whether a separate law or Quality Control Order makes it mandatory, Which edition must be followed, Whether testing or certification is required, Whether an existing licence or test report needs updating. This compliance update explains the eight standards, implementation dates, business impact, the BIS certification process, potential costs, and the steps organisations should take before the older editions are withdrawn. Key Highlights of the BIS Notification The most important takeaways are: Eight Indian Standards were established on 24 July 2026. Five standards pertain to the safety of household or commercial electrical appliances. Three standards relate to network security, metadata and software. Four standards replace earlier editions. The four previous editions remain valid until 24 January 2027. Four standards have no predecessor identified for withdrawal. The notification does not, by itself, impose blanket BIS certification. Businesses must separately check QCO, regulatory, contractual and procurement requirements. Companies using an older edition should begin their transition assessment immediately. Particular Details Issuing authority Bureau of Indian Standards Administrative department Department of Consumer Affairs Notification date 27 July 2026 Date of establishment 24 July 2026 Total standards established Eight Electrical-appliance standards Five Information-technology standards Three Standards replacing previous editions Four Standards without a predecessor listed Four Withdrawal date for previous editions 24 January 2027 Legal basis Rule 15 of the Bureau of Indian Standards Rules, 2018 Background of the BIS Standards Framework The Bureau of Indian Standards, or BIS, is India's national standards body, responsible for establishing, revising, amending, and withdrawing Indian Standards for goods, articles, processes, systems, and services. Indian Standards provide common benchmarks for areas such as: Product safety, Performance, Quality, Testing, Marking, Terminology, Interoperability, Information management, Technical procurement. BIS can formulate an Indian Standard domestically or adopt a standard developed by an international organisation. This explains why several standards in the notification reference IEC, ISO, or IEEE publications. Legal Basis of the Notification The notification was issued under Rule 15 of the Bureau of Indian Standards Rules, 2018. Rule 15 empowers BIS to establish Indian Standards and to reaffirm, amend, revise or withdraw them when required. The process normally involves consultation with technical experts, government bodies, industry representatives, laboratories, consumers and other stakeholders. The establishment, revision and withdrawal of Indian Standards are formally notified through the Official Gazette. Which Standards Have Been Established? S. No. Indian Standard Product or subject International reference Status Previous edition Withdrawal date 1 IS 302 (Part 2/Sec 16): 2026 Food waste disposers IEC 60335-2-16: 2022 No predecessor listed NA NA 2 IS 302 (Part 2/Sec 26): 2026 Electrical clocks IEC 60335-2-26: 2024 Second revision IS 302-2-26: 2014 24 January 2027 3 IS 302 (Part 2/Sec 36): 2026 Commercial electric cooking ranges, ovens, hobs and hob elements IEC 60335-2-36: 2021 No predecessor listed NA NA 4 IS 302 (Part 2/Sec 49): 2026 Commercial appliances for keeping food and crockery warm IEC 60335-2-49: 2021 No predecessor listed NA NA 5 IS 302 (Part 2/Sec 54): 2026 Household surface-cleaning appliances using liquids or steam IEC 60335-2-54: 2022 No predecessor listed NA NA 6 IS/ISO/IEC/IEEE 8802-1X: 2021 Port-based network access control ISO/IEC/IEEE 8802-1X First revision 2013 edition 24 January 2027 7 IS/ISO/IEC 11179-6: 2023 Metadata registry registration ISO/IEC 11179-6 First revision 2015 edition 24 January 2027 8 IS/ISO/IEC 14882: 2024 C++ programming language ISO/IEC 14882 Second revision 2020 edition 24 January 2027 Scope of the Notification The standards can be divided into two broad categories. Electrical-Appliance Safety The first five standards form part of the IS 302 series, which covers the safety of household and similar electrical appliances. These standards may be relevant to: Electrical-appliance manufacturers, Commercial-kitchen equipment companies, Domestic appliance brands, Importers, Foreign manufacturers, Distributors, Testing laboratories, Hotels and restaurants, Hospitals and institutional kitchens, Government and private procurement agencies. Information Technology and Software The remaining three standards relate to: Port-based network access control, Metadata registry registration, and The C++ programming language. These standards may be relevant to: Network-equipment manufacturers, Cybersecurity service providers, System integrators, Government IT departments, Data-governance teams, Software companies, Compiler developers, Embedded-system manufacturers, Technology procurement teams. The compliance implications are different for each group. An electrical product may be subject to product testing and certification if covered by a mandatory order. An IT or software standard may instead become relevant through procurement, contracts, technical policies, or voluntary adoption. Detailed Explanation of the Eight Standards 1. IS 302 (Part 2/Sec 16): 2026-Food Waste Disposers This standard is based on IEC 60335-2-16: 2022 and relates to the safety of electrically operated food waste disposers. Food waste disposers are typically installed in kitchen sink systems and are designed to break down food waste before disposal. The Gazette does not list an earlier Indian Standard for withdrawal. Businesses should therefore describe it as a standard for which no predecessor is identified in this notification. It should not be claimed that no other safety requirement was previously relevant to these appliances. Who Should Review This Standard? Food waste disposer manufacturers, Kitchen-appliance brands, Modular-kitchen businesses, Importers and distributors, Hotels and restaurants, Builders and institutional buyers, Product testing laboratories. Manufacturers and importers should first compare the product's intended use, design and electrical specifications with the precise scope of the complete standard. They should then check whether a QCO, certification scheme, tender or customer contract makes conformity compulsory. 2. IS 302 (Part 2/Sec 26): 2026-Electrical Clocks This standard is based on IEC 60335-2-26: 2024 and specifies particular safety requirements for electrical clocks. It is the second revision and replaces IS 302-2-26: 2014. However, the previous edition will remain valid until 24 January 2027. Manufacturers should analyze: Models tested in accordance with the 2014 version, Any BIS license that is in place, as applicable, Test reports, Product drawings, Critical parts, Markings and instructions for users, Applications pending, Specification of suppliers. The notification is not a summary of the technical differences between the 2014 and 2026 versions. The assessment of the transition will require a clause-by-clause comparison of all standards. 3. IS 302 (Part 2/Sec 36): 2026-Commercial Electric Cooking Appliances This standard is based on IEC 60335-2-36: 2021. It covers commercial electric cooking ranges, ovens, hobs and hob elements. The standard may be relevant to equipment used in: Hotels, Restaurants, Canteens, Hospitals, Cloud kitchens, Catering facilities, Institutional kitchens, Food-service businesses. No predecessor Indian Standard is identified for withdrawal in the notification. Commercial appliances can differ from ordinary household appliances in their intended use, operating environment, capacity and frequency of operation. A company should not classify a product solely by the words "oven" or "hob." The complete scope and definitions must be reviewed before beginning the BIS certification process. 4. IS 302 (Part 2/Sec 49): 2026-Appliances for Keeping Food and Crockery Warm This standard is based on IEC 60335-2-49: 2021. It concerns commercial electrical appliances used for keeping food or crockery warm. The standard may be relevant to manufacturers and suppliers serving: Restaurants, Hotels, Buffets, Hospitals, Catering businesses, Commercial cafeterias, Institutional kitchens. No previous Indian Standard is listed for withdrawal. Manufacturers should examine the product's commercial purpose, heating method, electrical characteristics and intended operating conditions before deciding that the standard applies. Institutional purchasers may also begin referring to this standard in procurement documents even where no independent QCO makes it mandatory. 5. IS 302 (Part 2/Sec 54): 2026-Liquid- and Steam-Based Surface Cleaners This standard is based on IEC 60335-2-54: 2022 and covers household surface-cleaning appliances that use liquids or steam. The exact scope must be checked before classifying steam cleaners, liquid-based cleaners, or multipurpose cleaning equipment under this standard. Possible impacted industries: Manufacturers of cleaning appliances, Brands of consumer electronics, Importers, Foreign manufacturers, Distributors, Online retailers, Product-testing labs. Importers need to conduct a BIS applicability study before placing a large purchase order or delivering products to India. Finding out that there is a mandatory compliance requirement after delivery could result in storage costs, delayed launches, and retesting. 6. IS/ISO/IEC/IEEE 8802-1X: 2021-Port-Based Network Access Control This standard concerns port-based network access control for local and metropolitan area networks. It replaces the 2013 edition, which is scheduled for withdrawal on 24 January 2027. Port-based network access control helps organisations manage how devices and users obtain access to network infrastructure. The standard may be relevant to: Network-equipment manufacturers, Enterprise security teams, Cybersecurity companies, System integration firms, Managed services providers, IT Projects by Government, Operators of Critical Infrastructure. Companies relying on the old version must carefully examine contracts, technical designs, procurement requirements, and product documentation. The notification does not require every organisation to redesign its network. Applicability may arise through customer requirements, security policies, contracts or public procurement. 7. IS/ISO/IEC 11179-6: 2023-Metadata Registry Registration This standard deals with the registration of metadata in a metadata registry. It replaces the 2015 edition, which will remain valid until 24 January 2027. Metadata registries help organisations maintain structured information about data elements. They may support: Data governance, Common definitions, Information exchange, Data interoperability, Institutional record management, Standardised data dictionaries. The standard may be relevant to government departments, financial institutions, healthcare organisations, digital platforms and large enterprises. Organisations using the previous edition should review their registration procedures, governance roles, metadata status models, approval mechanisms and related software requirements. 8. IS/ISO/IEC 14882: 2024-C++ Programming Language This standard relates to the C++ programming language and replaces the 2020 edition. The earlier edition will remain valid until 24 January 2027. The standard may be relevant to: Software developers, Compiler vendors, Embedded-system manufacturers, Automotive technology companies, Industrial software companies, Government technology projects, Organisations procuring safety-critical software. Its establishment does not mean that every developer using C++ must obtain BIS registration or certification. Its relevance is more likely to arise through compiler conformity, coding policies, technical contracts, procurement requirements, software development standards, or migration to newer C++ capabilities. What Has Changed? The notification creates three broad changes. Four Standards Have No Predecessor Listed No previous Indian Standard is identified for withdrawal for: Food waste disposers, Commercial electric cooking ranges, ovens and hobs, Commercial food- and crockery-warming appliances, Household liquid- or steam-based surface-cleaning appliances. This does not necessarily mean that these products were completely unregulated earlier. Another general safety standard, QCO certification condition, or sector-specific requirement may still be relevant. Four Standards Replace Previous Editions Older editions have been replaced for: Electrical clocks, Network access control, Metadata registry registration, C++ programming language. These previous editions remain concurrently valid until 24 January 2027. Greater Alignment With International Standards The notification adopts the latest editions of IEC, ISO, and IEEE as Indian Standards. This can help align Indian technical practices with more recent international requirements. However, businesses must use the complete Indian editions when determining domestic compliance. What the Notification Does Not Tell Businesses The Gazette identifies the standards, establishment dates, previous editions, and withdrawal dates. It does not provide: Complete technical requirements, Clause-by-clause changes, Product testing methods, Certification procedures, BIS licence fees, Factory-inspection requirements, Penalties for every affected business, Automatic confirmation that certification is mandatory. These questions require review of the complete standard and the applicable regulatory instrument. Implementation Timeline and Transition Norms Date or period Regulatory position Recommended business action 24 July 2026 All eight Indian Standards established Identify applicable products, systems and contracts 27 July 2026 BIS notification dated Begin legal and technical assessment July 2026 to January 2027 Old and new editions run concurrently for four revised standards Compare editions, update products and complete testing Before 24 January 2027 Transition-planning period Resolve certification, documentation and contractual issues 24 January 2027 Listed previous editions scheduled for withdrawal Move to the new edition, subject to applicable BIS directions After 24 January 2027 Previous editions no longer remain concurrently valid under this notification Maintain conformity with the applicable new edition What Does Concurrent Running Mean? Concurrent running allows two editions of an Indian Standard to remain valid for a specified period. Rule 28 of the Bureau of Indian Standards Rules, 2018 permits the Director General of BIS to allow concurrent operation of two versions and determine the transition period. Businesses should use this period for orderly migration. It should not be treated as a reason to wait until January 2027. What About Products Already in the Market? The notification does not provide a universal answer for products manufactured, tested, certified, or imported under an earlier edition. Businesses must separately check: Applicable BIS implementation guidelines, Existing licence conditions, QCO provisions, Acceptance of old test reports, Treatment of products already manufactured, Pending BIS applications, Existing inventory, Contractual obligations. Why Were These Standards Implemented? The notification does not provide a detailed policy explanation for each standard. However, the updates appear consistent with recognised standardisation objectives. Updating Electrical-Safety Benchmarks Electrical appliances and their components continue to evolve. Updated standards can provide more current benchmarks for design, construction, testing and safe use. Aligning India With International Standards The use of newer IEC, ISO and IEEE editions can reduce differences between Indian and international technical practices. This may help manufacturers operating in multiple markets, although Indian regulatory and certification requirements must still be assessed separately. Improving Network Security The network-access-control standard provides an updated technical reference for controlling access to local and metropolitan networks. Strengthening Data Governance The metadata-registry standard can support consistent data definitions, registration procedures and information exchange. Updating Software Specifications The new C++ edition provides a more up-to-date reference for developers, compiler vendors and organisations that specify C++ requirements in contracts or procurement. Impact on Businesses Impact on Manufacturers Manufacturers may need to review product designs, components, drawings, technical files, quality-control plans, testing capabilities, and existing certifications. Where the new edition contains materially different requirements, the manufacturer may need to: Modify product construction, Replace critical components, Update testing equipment, Conduct additional testing, Revise user instructions, Update product marking, Amend supplier specifications, Extend or change an existing licence. The actual changes cannot be confirmed from the Gazette alone. Impact on Importers Importers should check product compliance before placing orders or arranging shipment. A delayed regulatory assessment may result in: Shipment delays, Additional warehousing costs, Product testing after manufacture, Re-labelling, Supplier disputes, Delayed market launch, Certification expenses not included in the original budget. The manufacturer, rather than the importer, may need to hold the BIS licence under certain product-certification schemes. The correct applicant must be identified before filing. Impact on Foreign Manufacturers BIS certification for foreign manufacturers may involve additional documentation and coordination. Depending on the applicable scheme, the process may require: Appointment of an authorised Indian representative, Overseas-factory information, Product testing, Factory inspection, Travel and inspection expenditure, Brand authorisation, Ongoing representation in India. Foreign manufacturers should begin the process well before the planned Indian launch date. Impact on MSMEs Micro and small businesses may face a proportionately greater burden because they may not have: An in-house compliance department, Complete testing infrastructure, Dedicated regulatory personnel, Experience with BIS applications, Sufficient budget for repeated testing, Easy access to specialised laboratories. An early gap analysis can help an MSME avoid unnecessary product modifications and incorrect applications. Impact on Hotels, Restaurants and Institutional Buyers Hotels, hospitals, restaurants, canteens and commercial kitchens may be affected through procurement. Buyers may begin asking suppliers for: Updated conformity evidence, Valid BIS licences, where applicable, Test reports, Product-safety declarations, Confirmation of the relevant Indian Standard, Technical specifications aligned with the new edition. Impact on Technology Companies Technology businesses may need to review: Network-security architecture, IT procurement documents, Customer contracts, Metadata-governance procedures, Data dictionaries, Compiler support, Coding standards, Toolchain policies, Software migration plans. How Businesses Can Achieve Compliance A business should approach the notification through a structured process. Step 1: Complete an Applicability Assessment The business should begin with the product's: Intended use, Technical design, Electrical rating, User category, Operating environment, Manufacturing process, Commercial description. Similar products may fall under different standards. Choosing a standard based only on a product name can result in an incorrect BIS licence application. Step 2: Verify Mandatory Status Search for: Quality Control Orders, Product-specific BIS certification manuals, Regulatory notifications, Applicable conformity-assessment schemes, Tender requirements, Customer contracts, Sector-specific directions. This is one of the most important functions of a BIS certification consultant. Step 3: Obtain the Complete Standard The Gazette is only a notification. It cannot be used as a replacement for the complete technical standard. The complete standard must be reviewed for: Scope, Definitions, Classifications, Construction requirements, Safety requirements, Test methods, Marking, Documentation, Referenced standards. Step 4: Conduct a Gap Analysis For the updated standards, enterprises need to conduct a clause-by-clause comparison between the old and updated editions. Gap analysis will help determine: New requirements, New tests, New definitions, New classification, New references, Product design considerations, Changes in documentation, Requirement for retesting. Step 5: Prepare Technical Documentation Documents may include: Process chart for manufacturing, Factory layout, List of machinery, Testing equipment list, Calibration certificates, Drawings of products, Bills of material, Component specifications, Ratings of product, Product models, Quality control plan, Test reports, Trademark documents. The final document list depends on the product and BIS scheme. Step 6: Complete Product Testing Where testing is required, the business should verify: Laboratory recognition or acceptance, Testing scope, Sample quantity, Testing duration, Test charges, Report validity, Model-grouping rules, Retesting conditions. Choosing the wrong BIS testing laboratory can lead to an unusable report and repeated expenditure. Step 7: Submit the BIS Licence Application A complete application should correctly identify: Manufacturer, Manufacturing unit, Product category, Indian Standard, Product models, Brand, Applicable certification scheme, Test reports, Authorised representatives. Incomplete or inconsistent information can delay the BIS certification process. Step 8: Prepare for Factory Inspection Where factory inspection is required, the manufacturer should ensure that: Production facilities are operational, Testing equipment is available, Calibration certificates are valid, Quality-control procedures are implemented, Technical personnel are present, Records are properly maintained, Product samples can be drawn. Step 9: Update Product Marking The BIS Standard Mark must only be used under a valid licence and within its approved scope. Product marking may need to include: Licence number, Product identification, Model, Rating, Traceability information, Applicable statutory declarations, User and safety instructions. Step 10: Maintain Post-Certification Compliance BIS compliance continues after the licence is granted. Manufacturers may need to maintain: Routine test records, Calibration, Quality-control records, Supplier controls, Complaint records, Correct use of the Standard Mark, Surveillance readiness, Renewal documents, Change notifications, Compliance with later amendments. BIS Certification Cost There is no single BIS certification cost for every product. The total cost depends on the standard, product, certification scheme, testing requirements, and location of the manufacturing unit. Cost component Main factors affecting cost BIS application fee Certification scheme and number of applications Laboratory testing Product complexity, tests, samples and laboratory charges Inspection expenses Factory location and inspection requirements Foreign-manufacturer expenses Overseas inspection, travel and sample shipment Product redesign Nature and number of technical non-conformities Retesting Test failure, sample modification or additional models Marking fee Product category, production volume and licence conditions Professional charges Scope of BIS certification services required Internal compliance cost Staff, equipment, calibration and training Renewal and surveillance Applicable licence and continuing-compliance requirements Businesses should request a product-specific quotation rather than relying on a generic BIS certification cost displayed online. A basic quotation may not include: Government fees, Laboratory charges, Factory inspection, Travel expenses, Sample shipment, Product redesign, Retesting, Additional model coverage, Marking fees, Post-certification support. Risks of Ignoring the Updated Standards Even where a standard is not independently mandatory, ignoring it may create commercial or contractual risks. These can include: Rejection from government or private tenders, Failure to meet customer specifications, Use of an outdated technical reference, Rejection of test reports, Delayed BIS certification, Repeat testing, Product redesign after launch, Supplier disputes, Loss of customer confidence, Network-security weaknesses, Inconsistent metadata governance, Software compatibility issues. Where a separate QCO makes certification mandatory, non-compliance may also lead to enforcement under the applicable order and the BIS Act. The penalties should be linked to the mandatory instrument, not incorrectly attributed solely to this standards-establishment notification. Benefits for Businesses Improved Product Safety Updated electrical appliance standards can support safer product design, manufacturing, and testing. Greater International Alignment International coordination will help reduce the gap between the technical procedures followed in India and those defined internationally by the latest IEC, ISO, and IEEE standards. Better Market Credibility Conformity with recognised standards can improve confidence among customers, institutional buyers, and business partners. Clearer Procurement Standards make it possible for buyers to quantify specifications of products/systems/suppliers. Reduced Product Failure Risk Effective testing and quality control can reduce defects, complaints, recalls, and corrective action expenses. Stronger Network Security The port-based network access control standard can support more consistent authentication and access management practices. Improved Data Governance The metadata-registry standard can help organisations maintain consistent definitions and registration processes. Updated Software Practices The newer C++ standard provides a current reference for compilers, development policies, contracts and procurement. Is This the Right Decision or an Additional Burden? The notification represents necessary technical modernisation, but it may also create short-term costs. Why the Decision Is Beneficial The updated standards can: Replace outdated technical references, Increase product safety, Align internationally, Improve procurement processes, Ensure consistent testing, Improve network security, Support better data governance, Modernise software specifications. Why Businesses May See It as a Burden Businesses may need to spend money on: Purchasing the new standards, Technical interpretation, Product redesign, Laboratory testing, Retesting, BIS certification, Documentation, Supplier changes, Staff training, Software migration. The burden may be greater for MSMEs, foreign manufacturers, and companies with several products or manufacturing units. Balanced Assessment The new standards will be beneficial, as technical requirements change with evolving products and technologies. However, successful implementation depends on: Clear BIS transition guidelines, Adequate laboratory capacity, Reasonable certification timelines, Support for MSMEs, Transparent cost structures, Clarity on mandatory applicability. The standards themselves are not the main problem. The burden arises when businesses do not know whether a standard is mandatory, which edition applies, or what must be done with existing products and certificates. Business Opportunities Created The notification can create new commercial opportunities across compliance, engineering, and technology services. BIS Certification and Product Compliance Services Manufacturers and importers may need help with: Product classification, Standard selection, QCO applicability, BIS licence applications, Documentation, Testing, Inspection preparation, Post-certification compliance. Testing-Laboratory Services Testing laboratories may see increased demand for product evaluation under the new electrical-appliance standards. Product Redesign and Safety Engineering Manufacturers that are now opting for newer standards may require support with components, construction, technical drawings, and safety assessments. Foreign-Manufacturer Compliance Services International brands entering India may need assistance with BIS certification, local representation, testing, and factory inspections. Cybersecurity Consulting The network-access-control standard may create opportunities for: Network-security consultants, Authentication solution providers, System integrators, Security auditors, Managed service providers. Metadata and Data-Governance Services Organizations could seek help with their metadata registries, data dictionaries, governance procedures, and digital transformation projects. C++ Training and Migrations Software firms might need: Developer training, Compiler migration, Codebase analysis, Toolchain validation, Compatibility testing, Coding policy updates. Compliance Technology Platforms Businesses with several products may invest in software for: Certificate tracking, Regulatory monitoring, Test-report management, Supplier compliance, Product-model mapping, Renewal reminders. How Can Corpseed Help? The most difficult part of a BIS compliance update is not reading the standard's name. It is determining whether that standard applies to a specific product and what the business must do next. Corpseed can support manufacturers, importers, startups, and foreign companies through the following services. Product and Standard Applicability Assessment Corpseed can analyze the product description, specifications, purpose, and manufacturing process to determine which Indian Standard applies. This reduces the risk of choosing the wrong standard or submitting an unnecessary application. QCO and Mandatory-Status Assessment Before beginning certification, Corpseed can help determine whether the standard is: Voluntary, Covered by a QCO, Required by another regulation, Included in a tender, Contractually mandatory. BIS Certification Support Where certification is required, Corpseed can assist with: Document checklists, Application preparation, Online filing coordination, Response to application queries, Inspection preparation, Application tracking, Post-certification requirements. BIS Testing Laboratory Coordination Corpseed can help businesses understand the required tests, sample requirements, and appropriate laboratory route. Final laboratory selection must be based on the relevant standard, testing scope, and applicable BIS requirements. Transition Gap Analysis Businesses using a previous edition can be supported in comparing their existing products, reports, and documentation with the updated standard. This can help create a structured transition plan before 24 January 2027. Support for Foreign Manufacturers and Importers Assistance may include: India-specific regulatory mapping, Identification of applicant, Authorised Indian representative (AIR) requirements, Documentation, Testing coordination, Factory-inspection preparation, Application support. Compliance Documentation Corpseed can help organise: Product documents, Factory details, Testing records, Quality-control procedures, Brand authorisations, Technical declarations, Application forms. Regulatory Monitoring Future amendments, Quality Control Orders and implementation guidelines can change a business's obligations. Ongoing monitoring helps manufacturers and importers act before a deadline disrupts production, imports or sales. Corpseed can support the application and compliance process, but testing outcomes and licence approval remain subject to BIS requirements and the decision of the competent authority.

Subject

Summary: The Food Safety and Standards Authority of India ( FSSAI ) issued a corrigendum on 17 July 2026 to its technical specifications for high-end laboratory equipment. The FSSAI HEE specifications corrigendum 2026 changes one LC-MS/MS specification and one ICP-MS specification. For Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), the stated desorption temperature has changed from 500°C or better to 400°C or better. For Inductively Coupled Plasma Mass Spectrometry (ICP-MS), the high-mass-side figure has changed from ≤ 1 × 10⁻⁷ to ≤ 5 × 10⁻⁷. Other terms in the notice dated 10 December, 2025 remain unchanged. According to the FSSAI, these specifications are indicative. These specifications are neither standard specifications for tendering nor procurement norms. Notification at a Glance Particular Verified details Issuing authority Food Safety and Standards Authority of India, Quality Assurance Division Document type Corrigendum File number QA-11013/1/2025-QA-FSSAI eOffice reference I/39900/2026 Date of issue 17 July 2026 Original notice date 10 December 2025 Effective date Not expressly specified Governing framework FSSAI is established under the Food Safety and Standards Act, 2006. The document itself contains indicative procurement specifications Equipment covered by the original notice GC-MS/MS, LC-MS/MS, ICP-MS and ICP-OES Specifications amended LC-MS/MS and ICP-MS Main stakeholders Procuring agencies, food testing laboratories, Technical Committees, manufacturers, suppliers and bidders Compliance deadline Not expressly specified Nature of requirement Indicative and non-mandatory Fees or penalties Not specified The corrigendum is mainly relevant to laboratory procurement and tender evaluation. It does not introduce any business licence, registration, certification, or regulatory filing requirements. Background of the FSSAI Equipment Specifications FSSAI issued the original notice on 10 December 2025. It contained approved technical specifications for four categories of High-End Equipment (HEE): Gas Chromatography-Tandem Mass Spectrometry (GC-MS/MS) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and Inductively Coupled Plasma-Optical Emission Spectrometry (ICP-OES). These instruments support laboratory testing of food, agricultural products, water and other samples. They can help detect pesticide residues, veterinary drug residues, antibiotics, mycotoxins, contaminants and metals. The original annexures cover instrument performance, software, sample systems, accessories, power backup, gases, qualification, warranties, training, maintenance and technical bid evidence. The corrigendum does not replace those annexures. It corrects only two entries. The use of the word “approved” does not make every specification a compulsory legal standard. The corrigendum expressly states that the specifications are purely indicative. Why Was This Corrigendum Issued? The document was issued to correct two values in the original technical specifications. It does not give a separate scientific explanation for either correction. The corrected figures may help avoid the use of inaccurate conditions in future tenders, technical evaluations and compliance sheets. Any wider purpose, such as increasing supplier participation, would be a possible business effect rather than an objective expressly stated by FSSAI. What Has Changed? The corrigendum makes the following changes: Annexure II, Clause 6(vi), concerning the LC-MS/MS ionisation source, now uses a desolvation temperature of 400°C or better. Annexure III, Clause 6(ii)(b), concerning the ICP-MS mass analyser and detector, now uses a high-mass-side figure of ≤ 5 × 10⁻⁷. The ICP-MS low-mass-side figure remains ≤ 5 × 10⁻⁷. All remaining parts of the original notice continue without change. Old vs. Revised Technical Specifications Equipment and clause Earlier position Revised position Business meaning LC-MS/MS, Annexure II, Clause 6(vi) Desolvation temperature for ESI and APCI sources: 500°C or better Desolvation temperature for ESI and APCI sources: 400°C or better The stated temperature has been reduced by 100°C ICP-MS, Annexure III, Clause 6(ii)(b) High Mass Side: ≤ 1 × 10⁻⁷ High Mass Side: ≤ 5 × 10⁻⁷ The permitted numerical ceiling is higher Other provisions Original notice and four annexures No change Existing specifications continue unless a procuring agency modifies them The changes may affect whether certain equipment models fit a tender’s technical conditions. Final eligibility will still depend on the full tender and the operational needs of the procuring laboratory. Clause-Wise Explanation of the Technical Changes 1. LC-MS/MS ionisation source requirement LC-MS/MS is commonly used to measure pesticides, antibiotics, veterinary drug residues and mycotoxins. Its ionisation source converts sample molecules into charged particles before measurement. The original specification covers two ionisation methods: Electrospray Ionisation (ESI) and Atmospheric Pressure Chemical Ionisation (APCI). Desolvation uses heat to remove the solvent from charged droplets the earlier specification required a desolvation temperature of 500°C or higher for both sources. The corrected value is 400°C or better. This change may allow more LC-MS/MS models to fit the indicative condition. However, the corrigendum does not define what “or better” means. A procuring agency should assess the temperature range, source design, method performance, and sample needs together. A higher temperature should not automatically be treated as better for every instrument. Performance-based tender wording can reduce confusion. 2. ICP-MS mass analyser and detector requirement ICP-MS is used to detect metals at very low levels. The original specifications refer to testing food, seafood, water and other samples at parts-per-million, parts-per-billion and parts-per-trillion levels. Clause 6 covers the mass analyser and detector. The corrected part now reads: Mass range: 5–260 atomic mass units (amu) or better Low Mass Side: ≤ 5 × 10⁻⁷ and High Mass Side: ≤ 5 × 10⁻⁷. An atomic mass unit is used to express the mass of atoms and molecules. The source does not separately explain the unit or technical name for the low- and high-mass-side figures. The move from ≤ 1 × 10⁻⁷ to ≤ 5 × 10⁻⁷ raises the permitted maximum for the high-mass side. Numerically, this makes the single condition less strict. This is a technical inference from the revised figures, not an express conclusion stated by the FSSAI. 3. Specifications that remain unchanged No change has been made to the GC-MS/MS or ICP-OES annexures. For LC-MS/MS and ICP-MS, all conditions other than the two corrected values remain unchanged. Unchanged areas include instrument sensitivity, detection limits, software, workstations, autosamplers, gas systems, power backup, qualification, warranties, training, maintenance, accessories and performance documents. Scope and Applicability The corrigendum mainly affects stakeholders involved in selecting, supplying or evaluating high-end food testing equipment. Stakeholder Covered? Relevant effect Main responsibility Procuring agencies Yes May need to correct tender specifications Assess operational needs and finalise suitable conditions Food testing laboratories Yes May need to reassess equipment suitability Match the equipment with testing needs Technical Committees Yes May review or modify indicative values Prepare fair and technically clear specifications Equipment manufacturers and suppliers Yes May need to revise compliance statements Submit accurate, model-specific information Tender and bid teams Yes May need to update technical submissions Use corrected clauses and supporting evidence General food businesses Usually not directly No new operating duty is created Review only where involved in laboratory procurement The corrigendum does not create a general compliance duty for all food manufacturers, importers, distributors or sellers. Its direct use is connected with equipment procurement and technical evaluation. Nature of the Requirement: Indicative, Not Mandatory FSSAI clearly states that the specifications are purely indicative. They must not be treated as the standard tender specifications or mandatory procurement conditions. The source sets out the following procurement principles: Procuring agencies must independently assess their operational requirements. Agencies may modify any specification where needed. The specifications must not be read as favouring or restricting a manufacturer, technology, supplier or country of origin. Agencies may form their own Technical Committee (TEC). Subject-matter experts may be consulted before finalising tender specifications. FSSAI will not be liable for procurement or contractual issues arising from purchases made by other agencies. This distinction matters. A bidder should not be accepted or rejected only because a product matches or differs from an indicative value. The complete technical and operational position must be reviewed. Key Dates and Implementation Position Event Date Required response Original HEE specification notice 10 December 2025 Use as the base document Corrigendum 17 July 2026 Replace the two earlier values Separate effective date Not expressly specified Do not assume a retrospective date Compliance deadline Not expressly specified No statutory filing or transition deadline applies For an active tender that still contains the earlier figures, the procuring agency may need to decide whether a clarification or tender corrigendum is required. FSSAI does not prescribe a formal process for doing so. How Businesses Will Achieve Compliance? A practical roadmap for laboratories, agencies, and suppliers navigating this update: Whether the present or future purchase order of yours is based on LC-MS/MS or ICP-MS, the corrigendum will directly impact you. Revise the technical specifications documents to incorporate the updated desorption temperatures (≥400°C) and high mass-side sensitivity (≤5 × 10^-7) for LC-MS/MS and ICP-MS, respectively. Verify the compliance statement: If you have provided a compliance/non-compliance sheet based on the FSSAI specification table, ensure the values are from the corrigendum, not the 10 December 2025 version. Other specifications remain unchanged; this particular corrigendum affects only two data points. All other requirements in Annexure-II (LC-MS/MS) and Annexure-III (ICP-MS), including sensitivity, warranty, IQ/OQ/PQ, software, and accessories, remain the same as per the initial specifications. Documentation, manufacturer's certificate, hydrostatic test certificate, CCOE-Nagpur approval certificate, and purity certificate for gas cylinders will continue to be required. Consult the FSSAI website under "Advisories/Orders" and "Tenders/EOI" for the authoritative, current version of both the original notice and this corrigendum before finalising any bid. Common pitfall to be avoided: Depending on the cached or downloaded versions of the December 2025 notice, ignoring the fact that this corrigendum was issued. Given the change involved just two figures, this can be easily missed if one is not tracking the FSSAI advice. Impact on Businesses and Other Stakeholders Procuring agencies and laboratories Tender documents based on the December 2025 notice may contain outdated values. Procurement teams may need to recheck technical conditions and model evaluations. The correction may increase the number of systems that can be considered. However, laboratories must still review sensitivity, stability, sample type, workload, maintenance needs and service support. Manufacturers, suppliers and bidders Some LC-MS/MS or ICP-MS models that did not fit the earlier figures may fit the corrected position. This does not provide automatic tender eligibility. Suppliers may need to update: Clause-wise compliance statements Technical product comparisons Bid deviation notes Manufacturer literature Performance evidence and Tender clarification requests. Technical and procurement teams A review based only on the original notice may produce an incorrect result. The tender specification review should use both the original annexures and the corrigendum. No government fee is introduced. The likely cost relates to revising documents, reassessing models and repeating part of a technical evaluation. What Affected Businesses Should Do Next? The source does not create a formal compliance process. The following steps are practical tender controls based on the corrected provisions: Confirm the document version. Check whether internal files include the 17 July 2026 corrigendum. Replace both outdated values. Use 400°C or better for LC-MS/MS Clause 6(vi) and ≤ 5 × 10⁻⁷ for the ICP-MS high-mass side. Keep all other requirements unchanged. Do not treat the corrigendum as a new set of complete specifications. Review active tender documents. Identify tenders, technical sheets or evaluation reports that still use the earlier figures. Reassess equipment eligibility. Compare each model against the corrected values and the remaining adopted tender conditions. Update technical bid documents: correct compliance matrices, brochures, performance documents and deviation statements where required. Record technical decisions. Keep the reason for retaining, modifying or replacing an indicative specification. Benefits of the Corrected Specifications The corrigendum can provide several practical benefits: More accurate tender documents: Procurement teams can remove the two superseded values. Fairer technical evaluation: Suitable models are less likely to be excluded because of an incorrect figure. Wider equipment choice: The revised values may allow additional models to be considered. Improved documentation control: Laboratories may coordinate tender sheets, evaluation forms and compliance matrix. Improved clarity in supplier submissions: Bidders can submit evidence in response to the revised terms. Reduced disputes: Clear specifications will minimize unnecessary technical disputes. These benefits depend on careful tender drafting. The corrigendum does not guarantee a procurement result or commercial advantage. Practical and Technical Challenges The update is short, but implementation may still create difficulties: Old tender templates may still retain the earlier values. Active bids may require clarification or a revised technical sheet. The words “or better” may be interpreted differently by suppliers. Some evaluations may need to be repeated. Product literature may describe performance differently from the FSSAI table. Procurement teams must separate indicative guidance from mandatory tender conditions. The absence of a separate effective date may also create questions for tenders started before 17 July 2026. Procurement and Business Risks The corrigendum does not specify fines, suspension, prosecution or other statutory penalties. It is therefore incorrect to create a legal penalty section for this update. Reasonable business risks may still arise: An outdated value may wrongly exclude a suitable model. An inaccurate compliance statement may weaken a technical bid. Conflicting tender documents may lead to clarification requests or disputes. Manufacturer-specific wording may reduce fair competition. Failure to assess actual laboratory needs may result in the selection of unsuitable equipment. These are procurement and operational risks, not statutory consequences announced by FSSAI. Business Opportunities Created The corrected specifications may create opportunities in areas linked to laboratory procurement: Technical tender support for laboratories and suppliers Tender specification review and manufacturer-neutral drafting Bid compliance assessment Laboratory equipment selection support Technical document and performance-data review Technical Committee and procurement advisory services Installation qualification and performance planning Training, maintenance and application support. Equipment suppliers may also revisit opportunities where a model fits the corrected values but did not fit the earlier wording. Eligibility will still depend on the tender as a whole. Recommended Practices for Tender Compliance The following practices can help procurement and bid teams use the corrigendum correctly: Maintain one controlled copy of the original notice and corrigendum. Cite the corrected clause in tender and bid documents. Use performance-based language where possible. Define how “or better” will be assessed. Check claims against model-specific technical literature. Record the operational reason for each tender condition. Obtain expert input where specifications may restrict competition. Review all amendments before completing the technical evaluation. These are recommended controls. They are not additional legal duties created by FSSAI. Mistakes and Interpretation Risks to Avoid Stakeholders should avoid the following errors: Treating the corrigendum as a complete replacement for the original annexures Continuing to use 500°C for LC-MS/MS Clause 6(vi) Continuing to use ≤ 1 × 10⁻⁷ for the ICP-MS high-mass side Treating the indicative specifications as compulsory legal standards Assuming the issue date is also a stated effective date Applying the changes to GC-MS/MS or ICP-OES Claiming that a model automatically qualifies because it meets one corrected value and Ignoring the procuring agency’s independent technical assessment. These risks arise from the wording of the source and normal document-control concerns. FSSAI has not measured their frequency. Is the Corrigendum Necessary or an Additional Burden? The correction appears necessary because technical tenders depend on exact values. Even a small numerical error can change equipment eligibility and supplier participation. The LC-MS/MS revision may allow systems with a 400°C desolvation specification to be considered. The ICP-MS revision also relaxes the stated high-mass-side figure. Both changes may support a broader technical assessment. The short-term burden is mainly administrative. Procurement teams may have to revise tender sheets, recheck bids or issue clarifications. Suppliers may need to update technical submissions. The document takes a balanced approach by keeping the specifications indicative. Procuring agencies retain control over their final requirements. On balance, the correction is useful, provided it is applied with the original notice and not treated as a new mandatory standard. Future Outlook There are no other amendments announced by FSSAI, implementation process, or deadlines mentioned in the corrigendum. Speculation on other amendments would, thus, be baseless. Testing laboratories and equipment suppliers must monitor the advisories and tender pages for any further corrigenda or equipment specifications issued by FSSAI. The document control process within organizations must ensure that each amendment is linked back to its original notice. Key Takeaways The FSSAI HEE specifications corrigendum 2026 corrects two technical values. The LC-MS/MS desolation temperature is now 400°C or better. The ICP-MS high-mass-side figure is now ≤ 5 × 10⁻⁷. The update mainly affects laboratories, procuring agencies, Technical Committees, equipment suppliers and bidders. There is no stated compliance deadline or statutory penalty. The immediate priority is to update tender documents and technical evaluations while keeping the rest of the 10 December 2025 specifications unchanged. How Can Corpseed Help? Corpseed can assist laboratories, equipment suppliers, bidders and procurement teams with document-specific technical tender support. Relevant services include: Applicability and corrigendum assessment Tender specification review Clause-wise bid compliance assessment Technical bid consulting Compliance matrix preparation and review Product literature and performance-document review Manufacturer-neutral specification support and Procurement advisory services. Corpseed helps identify inconsistencies, missing evidence and outdated technical conditions. Final tender requirements, equipment selection and procurement decisions remain with the responsible authority. Laboratories and suppliers requiring tender compliance services or technical bid support can contact Corpseed for a focused review of the original FSSAI specifications, the corrigendum and the relevant procurement documents.